KR102530095B1 - Organic light-emitting compound and organic electroluminescent device using the same - Google Patents

Organic light-emitting compound and organic electroluminescent device using the same Download PDF

Info

Publication number
KR102530095B1
KR102530095B1 KR1020150171546A KR20150171546A KR102530095B1 KR 102530095 B1 KR102530095 B1 KR 102530095B1 KR 1020150171546 A KR1020150171546 A KR 1020150171546A KR 20150171546 A KR20150171546 A KR 20150171546A KR 102530095 B1 KR102530095 B1 KR 102530095B1
Authority
KR
South Korea
Prior art keywords
group
mmol
synthesis
formula
same
Prior art date
Application number
KR1020150171546A
Other languages
Korean (ko)
Other versions
KR20170065291A (en
Inventor
조현종
김영배
김회문
라종규
Original Assignee
솔루스첨단소재 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔루스첨단소재 주식회사 filed Critical 솔루스첨단소재 주식회사
Priority to KR1020150171546A priority Critical patent/KR102530095B1/en
Priority to PCT/KR2016/013721 priority patent/WO2017095086A1/en
Publication of KR20170065291A publication Critical patent/KR20170065291A/en
Application granted granted Critical
Publication of KR102530095B1 publication Critical patent/KR102530095B1/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/125OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light
    • H10K50/13OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 신규 유기 전계 발광 화합물 및 이를 이용한 유기 전계 발광 소자에 관한 것으로, 보다 상세하게는 정공 주입능 및 수송능, 전자 주입능 및 수송능, 발광능이 우수한 신규 화합물 및 이를 하나 이상의 유기물층에 포함함으로써, 높은 발광효율, 낮은 구동전압, 긴 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device using the same, and more particularly, to a novel compound having excellent hole injecting and transporting ability, electron injecting and transporting ability, and light emitting ability, and by including the same in one or more organic material layers. , It relates to an organic electroluminescent device with improved characteristics such as high luminous efficiency, low driving voltage, and long lifespan.

Description

유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자{ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME}Organic light emitting compound and organic electroluminescent device using the same

본 발명은 신규 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자에 관한 것으로, 보다 상세하게는 정공 주입능 및 수송능, 전자 주입능 및 수송능, 발광능 등이 우수한 신규 화합물 및 이를 하나 이상의 유기물층에 포함함으로써, 발광효율, 구동전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic light emitting compound and an organic electroluminescent device using the same, and more particularly, to a novel compound having excellent hole injecting and transporting ability, electron injecting and transporting ability, and light emitting ability, and including the same in at least one organic material layer. By doing so, it relates to an organic electroluminescent device with improved characteristics such as luminous efficiency, driving voltage, and lifetime.

1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. Research on organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices'), starting with Bernanose's observation of organic thin film emission in the 1950s and leading to blue electroluminescence using anthracene single crystal in 1965, was conducted in 1987. (Tang) proposed an organic EL device with a laminated structure divided into a hole layer and a functional layer of a light emitting layer. Since then, in order to make a high-efficiency, long-life organic EL device, it has been developed in the form of introducing each characteristic organic material layer in the device, leading to the development of specialized materials used therein.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons are injected into the organic material layer from the cathode. When the injected holes and electrons meet, excitons are formed, and when these excitons fall to the ground state, light is emitted. At this time, the material used as the organic material layer may be classified according to its function into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material, and the like.

유기 EL 소자의 발광층 형성재료는 발광색에 따라 청색, 녹색, 적색 발광 재료로 구분될 수 있다. 그밖에, 보다 나은 천연색을 구현하기 위한 발광재료로 노란색 및 주황색 발광재료도 사용된다. 또한, 색순도의 증가와 에너지 전이를 통한 발광효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. Materials for forming the light emitting layer of the organic EL device may be classified into blue, green, and red light emitting materials according to the light emitting color. In addition, yellow and orange light emitting materials are also used as light emitting materials for implementing better natural colors. In addition, in order to increase color purity and increase luminous efficiency through energy transfer, a host/dopant system may be used as a light emitting material.

도펀트 물질은 유기 물질을 사용하는 형광 도펀트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도펀트로 나눌 수 있다. 이러한 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광효율을 향상시킬 수 있어 인광 도펀트뿐만 아니라 인광 호스트 재료들에 대해 관심이 집중되고 있다. The dopant material may be divided into a phosphorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of such a phosphorescent material can theoretically improve luminous efficiency up to 4 times compared to fluorescence, so attention is focused on phosphorescent host materials as well as phosphorescent dopants.

현재까지 정공 주입층, 정공 수송층, 정공 차단층, 전자 수송층으로는, 하기 화학식으로 표현된 NPB, BCP, Alq3 등이 널리 알려져 있고, 발광 재료는 안트라센 유도체들이 형광 도펀트/호스트 재료로서 보고되고 있다. 특히 발광재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료로서는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색, 녹색, 적색 도펀트 재료로 사용되고 있다. 현재까지는 CBP가 인광 호스트 재료로 우수한 특성을 나타내고 있다. Until now, NPB, BCP, Alq 3 and the like represented by the following chemical formulas have been widely known as hole injection layers, hole transport layers, hole blocking layers, and electron transport layers, and anthracene derivatives have been reported as fluorescent dopant/host materials for light emitting materials. . In particular, as a phosphorescent material that has a great advantage in terms of efficiency improvement among light emitting materials, metal complex compounds containing Ir such as Firpic, Ir(ppy) 3 , and (acac)Ir(btp) 2 are used as blue, green, and red dopant materials. It is being used. So far, CBP has shown excellent properties as a phosphorescent host material.

Figure 112015118508351-pat00001
Figure 112015118508351-pat00001

Figure 112015118508351-pat00002
Figure 112015118508351-pat00002

그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 유기 EL 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있다. However, conventional materials are advantageous in terms of light emitting properties, but have low glass transition temperatures and very poor thermal stability, so they are not satisfactory in terms of lifetime in organic EL devices.

일본 공개특허공보 특개2001-160489Japanese Unexamined Patent Publication No. 2001-160489

상기한 문제점을 해결하기 위해, 본 발명은 유기 전계 발광 소자에 적용할 수 있으며, 정공 주입능 및 수송능, 전자 주입능 및 수송능, 발광능 등이 우수한 신규 유기 화합물을 제공하는 것을 목적으로 한다. In order to solve the above problems, an object of the present invention is to provide a novel organic compound that can be applied to an organic electroluminescent device and has excellent hole injection and transport capabilities, electron injection and transport capabilities, and luminescent performance. .

또한, 본 발명은 상기 신규 유기 화합물을 포함하여 낮은 구동전압과 높은 발광효율을 나타내며 수명이 향상되는 유기 전계 발광 소자를 제공하는 것을 또 다른 목적으로 한다.In addition, another object of the present invention is to provide an organic electroluminescent device exhibiting a low driving voltage and high luminous efficiency and having an improved lifetime, including the novel organic compound.

상기 목적을 달성하기 위하여, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to achieve the above object, the present invention provides a compound represented by Formula 1 below.

Figure 112015118508351-pat00003
Figure 112015118508351-pat00003

상기 화학식 1에서,In Formula 1,

X1 및 X2는 서로 동일하거나 상이하며, 각각 독립적으로 N(Ar1) 또는 C(Ar2)(Ar3)이고, 이때 X1 및 X2 중 적어도 하나는 N(Ar1)이고;X 1 and X 2 are the same as or different from each other, and are each independently N(Ar 1 ) or C(Ar 2 )(Ar 3 ), wherein at least one of X 1 and X 2 is N(Ar 1 );

Ar1 내지 Ar3는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있고;Ar 1 to Ar 3 are the same as or different from each other, and are each independently hydrogen, heavy hydrogen, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyl Oxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl It is selected from the group consisting of a boron group, a C 6 ~ C 60 arylphosphine group, a C 6 ~ C 60 arylphosphine oxide group, and a C 6 ~ C 60 arylamine group, or is combined with an adjacent group to form a condensed ring. can;

Y1 내지 Y12는 서로 동일하거나 상이하며, 각각 독립적으로 N 또는 C이고;Y 1 to Y 12 are the same as or different from each other, and are each independently N or C;

a 내지 c는 각각 독립적으로 0 내지 4의 정수로서, a 내지 c가 각각 독립적으로 1 내지 3의 정수인 경우, R1 내지 R3은 서로 동일하거나 상이하며, 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있고, 이때 R1 내지 R3이 각각 복수인 경우, 이들은 동일하거나 상이하며;a to c are each independently an integer of 0 to 4, and when a to c are each independently an integer of 1 to 3, R 1 to R 3 are the same as or different from each other, and each independently deuterium, a halogen, a cyano group, Nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group And C 6 ~ C 60 It is selected from the group consisting of an arylamine group, or may be combined with adjacent groups to form a condensed ring, wherein when R 1 to R 3 are plural, they are the same or different;

다만, R1 내지 R3 중 적어도 하나는 C6~C60의 아릴기 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택되고;However, at least one of R 1 to R 3 is selected from the group consisting of a C 6 ~ C 60 aryl group and a heteroaryl group having 5 to 60 nuclear atoms;

상기 Ar1 내지 Ar3, R1 내지 R3 의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다.An alkyl group , an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, and an arylsilyl group of Ar 1 to Ar 3 , R 1 to R 3 , Alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl amine group are each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group and C 6 ~ C 60 arylamine group to be substituted with one or more substituents selected from the group consisting of In this case, when the substituents are plural, they may be the same as or different from each other.

또한, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하고, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다. In addition, the present invention includes an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and at least one of the one or more organic material layers includes organic electroluminescence containing the compound represented by Formula 1 above. provide a small

여기서, 상기 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광층, 수명 개선층, 전자 수송층 및 전자 주입층을 포함할 수 있고, 이때 상기 화학식 1로 표시되는 화합물을 포함하는 1층 이상의 유기물층은 정공 수송층, 전자 수송층, 발광층 또는 수명 개선층인 것일 수 있다.Here, the one or more organic material layers may include a hole injection layer, a hole transport layer, a light emitting layer, a lifespan improvement layer, an electron transport layer, and an electron injection layer. It may be a transport layer, an electron transport layer, a light emitting layer, or a lifespan improvement layer.

본 발명에 따른 화학식 1로 표시되는 화합물은 열적 안정성 및 발광 특성이 우수하기 때문에 유기 전계 발광 소자의 유기물층 재료로 사용될 수 있다. Since the compound represented by Chemical Formula 1 according to the present invention has excellent thermal stability and emission characteristics, it can be used as a material for an organic layer of an organic electroluminescent device.

특히, 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자에 적용할 경우에는 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능 및 수명이 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다.In particular, when the compound represented by Formula 1 of the present invention is applied to an organic electroluminescent device, an organic electroluminescent device having excellent light emitting performance, low driving voltage, high efficiency and long lifespan can be manufactured, and furthermore, performance and lifespan are improved. Improved full color display panels can also be manufactured.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

1. 신규 화합물1. New compounds

본 발명에 따른 신규 화합물은 디벤조아제핀(5H-dibenzo[b,f]azepine) 또는 디벤조싸이클로헵텐(5H-dibenzo[a,d]cycloheptene)에 벤젠이 축합된 5원 헤테로환 모이어티(moiety)가 축합되어 기본 골격을 이루며, 상기 화학식 1로 표시되는 것을 특징으로 한다.The novel compound according to the present invention is a 5-membered heterocyclic moiety in which benzene is condensed with dibenzoazepine (5H-dibenzo[b,f]azepine) or dibenzocycloheptene (5H-dibenzo[a,d]cycloheptene). moiety) is condensed to form a basic skeleton, and is characterized in that it is represented by Formula 1 above.

보다 구체적으로, 상기 화학식 1로 표시되는 화합물은 디벤조아제핀(5H-dibenzo[b,f]azepine)에 인돌 모이어티(indole moiety)가 축합되거나 디벤조싸이클로헵텐(5Hdibenzo[a,d]cycloheptene)에 인돌 모이어티(indole moiety)가 축합되며, 각각의 N가 아릴기(구체적으로, 페닐기), 헤테로아릴기, 아릴아민기로 치환된 구조를 기본 골격으로 구조를 기본 골격으로 하는 것을 특징으로 한다.More specifically, the compound represented by Formula 1 may be obtained by condensation of an indole moiety to dibenzoazepine (5H-dibenzo[b,f]azepine) or dibenzocycloheptene (5Hdibenzo[a,d]cycloheptene). ) is condensed with an indole moiety, and each N is substituted with an aryl group (specifically, a phenyl group), a heteroaryl group, or an arylamine group as a basic skeleton. .

이러한 화학식 1로 표시되는 화합물은 종래 유기 전계 발광 소자용 재료[예: 4,4-dicarbazolybiphenyl (이하, 'CBP'라 함)] 보다 높은 분자량을 갖기 때문에 유리전이온도가 높아 열적 안정성이 우수할 뿐만 아니라 정공 주입능, 정공 수송능, 발광능 등이 우수하다. 따라서, 상기 화학식 1의 화합물을 유기 전계 발광 소자의 유기물층에 적용할 경우, 소자의 구동전압, 효율, 수명 등이 향상될 수 있다.Since the compound represented by Formula 1 has a higher molecular weight than conventional materials for organic electroluminescent devices [eg, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')], it has excellent thermal stability as well as a high glass transition temperature. In addition, it has excellent hole injection ability, hole transport ability, and luminous ability. Therefore, when the compound of Chemical Formula 1 is applied to the organic material layer of the organic electroluminescent device, the driving voltage, efficiency, and lifetime of the device can be improved.

보다 구체적으로, 본 발명에 따른 화학식 1 의 화합물은 상기 기본 골격의 N가 아닌 벤젠 고리에 다양한 종류의 치환기가 도입됨에 따라 우수한 정공 수송능 및/또는 전자 수송능을 가질 수 있다. 따라서, 상기 화학식 1의 화합물은 일정 수준 이상의 정공 이동도(Hole mobility) 또는 전자 이동도(electron mobility)를 갖는 유기 전계 발광 소자의 유기물층(구체적으로, 정공 수송층)으로 사용될 수 있다.More specifically, the compound represented by Formula 1 according to the present invention may have excellent hole transport and/or electron transport capabilities as various substituents are introduced to the non-N benzene ring of the basic skeleton. Accordingly, the compound of Chemical Formula 1 may be used as an organic material layer (specifically, a hole transport layer) of an organic EL device having hole mobility or electron mobility of a certain level or higher.

또한, 본 발명에 따른 화학식 1의 화합물은 상기 기본 골격의 벤젠 고리에 아릴기, 질소-함유 헤테로아릴기(예컨대, 피리딘기, 피리미딘기, 트리아진기 등), 아릴아민기와 같이 전자 흡수성이 큰 전자 끌개기(EWG)가 결합될 경우, 분자 전체가 바이폴라(bipolar) 특성을 갖기 때문에 정공과 전자의 결합력을 높일 수 있다. 따라서, 상기 화학식 1의 화합물은 우수한 발광 특성을 나타낼 수 있어, 유기 전계 발광 소자의 청색, 녹색 또는 적색의 인광 발광층 재료로 유용하게 적용할 수 있다. In addition, the compound of Formula 1 according to the present invention has a high electron absorption such as an aryl group, a nitrogen-containing heteroaryl group (eg, a pyridine group, a pyrimidine group, a triazine group, etc.) or an arylamine group on the benzene ring of the basic skeleton. When electron withdrawing (EWG) is combined, since the entire molecule has a bipolar characteristic, the bonding force between holes and electrons can be increased. Accordingly, the compound of Chemical Formula 1 can exhibit excellent light emitting properties, and thus can be usefully applied as a material for a blue, green or red phosphorescent light emitting layer of an organic electroluminescent device.

한편, 본 발명에 따른 화학식 1의 화합물에서, 탄소와 질소가 직접 결합(C-N 결합)할 경우에는 탄소와 탄소가 직접 결합(C-C 결합)할 경우에 비해 결합 구조가 틀어지거나 공액이 깨질 수 있다. 따라서, 상기 화학식 1의 화합물은 상기 기본 골격의 탄소와 전자끌개기(EWG)의 탄소가 결합하도록 배치함으로써 공액계를 확장할 수 있으며, 이로 인해 장파장의 발광 재료나 긴 공액계를 가지는 발광보조 재료로 적용할 수 있다.On the other hand, in the compound of Formula 1 according to the present invention, when carbon and nitrogen are directly bonded (C-N bond), the bond structure is distorted or the conjugate may be broken compared to when carbon and carbon are directly bonded (C-C bond). Therefore, the compound of Formula 1 can expand the conjugation system by arranging the carbon of the basic skeleton and the carbon of the electron withdrawing group (EWG) to be bonded, and thus, a light emitting material with a long wavelength or an auxiliary light emitting material having a long conjugated system. can be applied as

일반적으로 유기 전계 발광 소자의 인광 발광층에서는 호스트 물질의 삼중항 에너지 갭이 도펀트 물질의 삼중항 에너지 갭보다 높아야 한다. 즉, 도펀트로부터 효과적으로 인광 발광을 제공하기 위해서는 호스트의 가장 낮은 여기 상태가 도펀트의 가장 낮은 방출 상태보다 에너지가 더 높아야 한다. 상기 화학식 1로 표시되는 화합물은 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 축합된 인돌 모이어티에 특정의 치환기(예컨대, 아릴기, 헤테로아릴기, 아릴아민기)가 도입됨으로써, 에너지 준위가 도펀트보다 높게 조절될 수 있어 호스트 물질로 사용될 수 있다.In general, in a phosphorescent layer of an organic electroluminescent device, a triplet energy gap of a host material should be higher than a triplet energy gap of a dopant material. That is, in order to effectively provide phosphorescent light emission from the dopant, the lowest excited state of the host must have higher energy than the lowest emission state of the dopant. In the compound represented by Formula 1, a specific substituent (eg, an aryl group, a heteroaryl group, an arylamine group) is introduced into a condensed indole moiety having a wide singlet energy level and a high triplet energy level, thereby increasing the energy level. It can be adjusted higher than the dopant and can be used as a host material.

이와 같이, 상기 화학식 1로 표시되는 화합물은 유기 전계 발광 소자의 인광 특성을 향상시킬 뿐만 아니라 정공 주입/수송 능력, 발광효율, 구동전압, 수명 특성 등을 향상시킬 수 있고, 도입되는 치환체의 종류에 따라 전자 수송 능력 등도 향상시킬 수 있다. 따라서, 본 발명에 따른 화학식 1의 화합물은 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료(청색, 녹색 및/또는 적색의 인광 호스트 재료), 정공 및 전자 수송층 재료, 정공 및 전자 주입층 재료, 수명 개선층 재료, 더 바람직하게는 인광 발광층 재료, 정공 및 전자 수송층 재료, 수명 개선층 재료로 사용될 수 있다.As such, the compound represented by Chemical Formula 1 can improve not only the phosphorescent properties of the organic electroluminescent device but also the hole injection/transport capability, luminous efficiency, driving voltage, and lifetime characteristics, etc., depending on the type of substituent introduced. Accordingly, the electron transport ability and the like can be improved. Therefore, the compound of Formula 1 according to the present invention is an organic material layer material of an organic electroluminescent device, preferably a light emitting layer material (blue, green and/or red phosphorescent host material), a hole and electron transport layer material, and a hole and electron injection layer material. , a lifespan improving layer material, more preferably a phosphorescent light emitting layer material, a hole and electron transport layer material, and a lifespan improving layer material.

또한, 상기 화학식 1의 화합물은 상기 기본 골격에 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리 전이온도가 향상되고, 이로 인해 종래의 발광 재료(예를 들어, CBP)보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다. 따라서, 본 발명에 따른 화학식 1의 화합물을 포함하는 유기 전계 발광 소자는 성능 및 수명 특성이 크게 향상될 수 있다. 이러한 성능 및 수명 특성이 향상된 유기 전계 발광 소자는 결과적으로 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.In addition, the compound of Formula 1 is introduced with various substituents, in particular, an aryl group and/or a heteroaryl group to the basic skeleton to significantly increase the molecular weight of the compound, thereby improving the glass transition temperature, thereby improving conventional light emitting materials ( For example, CBP) may have higher thermal stability. In addition, the compound represented by Chemical Formula 1 is effective in inhibiting crystallization of the organic material layer. Therefore, the performance and lifetime characteristics of the organic EL device including the compound of Formula 1 according to the present invention can be greatly improved. As a result, the organic light emitting device having improved performance and lifespan characteristics can maximize the performance of a full-color organic light emitting panel.

즉, 본 발명에 따른 화학식 1의 화합물을 유기 전계 발광 소자의 정공 및 전자 주입/수송층 재료 또는 청색, 녹색 및/또는 적색의 인광 호스트 재료로 사용할 경우, 종래의 유기물층 재료(예를 들어, CBP) 비해 유기 전계 발광 소자의 효율 및 수명을 크게 향상시킬 수 있다. 또한, 이러한 유기 전계 발광 소자 수명 향상은 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.That is, when the compound of Formula 1 according to the present invention is used as a hole and electron injection/transport layer material or a blue, green and/or red phosphorescent host material of an organic electroluminescent device, a conventional organic material layer material (eg, CBP) In comparison, the efficiency and lifetime of the organic EL device can be greatly improved. In addition, the lifespan of the organic light emitting device can be improved to maximize the performance of the full color organic light emitting panel.

본 발명에 따른 신규 화합물은 상기 화학식 1로 표시되는 화합물이다.A novel compound according to the present invention is a compound represented by Formula 1 above.

보다 구체적으로, 상기 화학식 1로 표시되는 화합물에서, X1 및 X2는 서로 동일하거나 상이하며, 각각 독립적으로 N(Ar1) 또는 C(Ar2)(Ar3)이다. 이때, X1 및 X2 중 적어도 하나는 N(Ar1)이다.More specifically, in the compound represented by Formula 1, X 1 and X 2 are the same as or different from each other, and each independently represents N(Ar 1 ) or C(Ar 2 )(Ar 3 ). At this time, at least one of X 1 and X 2 is N(Ar 1 ).

Ar1 내지 Ar3는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있다. 바람직하게는, 상기 Ar1 내지 Ar3는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있다.Ar 1 to Ar 3 are the same as or different from each other, and are each independently hydrogen, heavy hydrogen, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyl Oxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl It is selected from the group consisting of a boron group, a C 6 ~ C 60 arylphosphine group, a C 6 ~ C 60 arylphosphine oxide group, and a C 6 ~ C 60 arylamine group, or is combined with an adjacent group to form a condensed ring. can Preferably, Ar 1 to Ar 3 are the same as or different from each other, and each independently represents hydrogen, heavy hydrogen, a C 1 ~ C 40 alkyl group, a C 6 ~ C 60 aryl group, or a heteroaryl having 5 to 60 nuclear atoms. It is selected from the group consisting of a group and a C 6 ~ C 60 arylamine group, or may be bonded to an adjacent group to form a condensed ring.

Y1 내지 Y12는 서로 동일하거나 상이하며, 각각 독립적으로 N 또는 C이다. 바람직하게는, 상기 Y1 내지 Y12는 모두 C이다.Y 1 to Y 12 are the same as or different from each other, and are each independently N or C. Preferably, all of Y 1 to Y 12 are C.

a 내지 c는 각각 독립적으로 0 내지 4의 정수이다. 이때, a 내지 c가 각각 독립적으로 0인 경우, 수소가 각각의 치환기 R1 내지 R3로 치환되지 않는 것을 의미한다. 또한, a 내지 c가 각각 독립적으로 1 내지 4의 정수인 경우, R1 내지 R3은 서로 동일하거나 상이하며, 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 이때 R1 내지 R3이 각각 복수인 경우, 이들은 동일하거나 상이하다. 바람직하게는, 상기 R1 내지 R3는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있다. 다만, R1 내지 R3 중 적어도 하나는 C6~C60의 아릴기 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택된다. a to c are each independently an integer of 0 to 4; At this time, when a to c are each independently 0, it means that hydrogen is not substituted with each of the substituents R 1 to R 3 . In addition, when a to c are each independently an integer of 1 to 4, R 1 to R 3 are the same as or different from each other, and each independently deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 nuclear atoms to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ A group consisting of a C 40 alkyl boron group, a C 6 ~ C 60 aryl boron group, a C 6 ~ C 60 arylphosphine group, a C 6 ~ C 60 arylphosphine oxide group, and a C 6 ~ C 60 arylamine group It is selected from, or may be bonded to an adjacent group to form a condensed ring, wherein, when R 1 to R 3 are each plural, they are the same or different. Preferably, R 1 to R 3 are the same as or different from each other, and each independently represents hydrogen, heavy hydrogen, a C 1 ~ C 40 alkyl group, a C 6 ~ C 60 aryl group, or a heteroaryl having 5 to 60 nuclear atoms. It is selected from the group consisting of a group and a C 6 ~ C 60 arylamine group, or may be bonded to an adjacent group to form a condensed ring. However, at least one of R 1 to R 3 is selected from the group consisting of a C 6 ~ C 60 aryl group and a heteroaryl group having 5 to 60 nuclear atoms.

이때, 상기 Ar1 내지 Ar3, R1 내지 R3 의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다. In this case, an alkyl group , an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, or an aryl of Ar 1 to Ar 3 , R 1 to R 3 A silyl group, an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group, and an arylamine group are each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group , C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, At least one substituent selected from the group consisting of C 6 ~ C 60 arylboron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 arylphosphine oxide group and C 6 ~ C 60 arylamine group In this case, when the substituents are plural, they may be the same as or different from each other.

이러한 화학식 1로 표시되는 화합물은 하기 화학식 2 또는 3으로 구체화될 수 있다.The compound represented by Formula 1 may be embodied by Formula 2 or 3 below.

Figure 112015118508351-pat00004
Figure 112015118508351-pat00004

Figure 112015118508351-pat00005
Figure 112015118508351-pat00005

상기 화학식 2 및 3에서,In Formulas 2 and 3,

Ar1 내지 Ar3, Y1 내지 Y12, a 내지 c, R1 내지 R3는 각각 상기 화학식 1에서 정의한 바와 같다.Ar 1 to Ar 3 , Y 1 to Y 12 , a to c, and R 1 to R 3 are each as defined in Formula 1 above.

보다 구체적으로, 상기 화학식 2로 표시되는 화합물은 하기 화학식 4 내지 7 중 어느 하나로 구체화될 수 있다.More specifically, the compound represented by Formula 2 may be embodied in any one of Formulas 4 to 7 below.

Figure 112015118508351-pat00006
Figure 112015118508351-pat00006

Figure 112015118508351-pat00007
Figure 112015118508351-pat00007

Figure 112015118508351-pat00008
Figure 112015118508351-pat00008

Figure 112015118508351-pat00009
Figure 112015118508351-pat00009

상기 화학식 4 내지 7에서,In Formulas 4 to 7,

Y1 내지 Y12, a 내지 c, R1 내지 R3는 각각 상기 화학식 1에서 정의한 바와 같다.Y 1 to Y 12 , a to c, and R 1 to R 3 are each as defined in Formula 1 above.

d 및 e는 각각 독립적으로 0 내지 5의 정수이고, f는 0 내지 4의 정수이다. 이때, d 내지 f가 각각 독립적으로 0인 경우, 수소가 각각의 치환기 R4 내지 R6로 치환되지 않는 것을 의미한다. 또한, d 및 e가 각각 독립적으로 1 내지 5의 정수이고, f가 1 내지 4의 정수인 경우, R4 내지 R6은 서로 동일하거나 상이하며, 각각 독립적으로 중수소, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 이때 R4 내지 R6이 각각 복수인 경우, 이들은 동일하거나 상이하다.d and e are each independently an integer of 0 to 5, and f is an integer of 0 to 4. At this time, when d to f are each independently 0, it means that hydrogen is not substituted with each of the substituents R 4 to R 6 . In addition, when d and e are each independently an integer of 1 to 5, and f is an integer of 1 to 4, R 4 to R 6 are the same as or different from each other, and each independently deuterium, a C 1 to C 40 alkyl group, It is selected from the group consisting of a C 6 ~ C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, and a C 6 ~ C 60 arylamine group, or may be combined with an adjacent group to form a condensed ring, wherein R When 4 to R 6 are each plural, they are the same or different.

또한, 상기 화학식 3으로 표시되는 화합물은 하기 화학식 8 내지 11 중 어느 하나로 구체화될 수 있다.In addition, the compound represented by Formula 3 may be embodied by any one of Formulas 8 to 11 below.

Figure 112015118508351-pat00010
Figure 112015118508351-pat00010

Figure 112015118508351-pat00011
Figure 112015118508351-pat00011

Figure 112015118508351-pat00012
Figure 112015118508351-pat00012

Figure 112015118508351-pat00013
Figure 112015118508351-pat00013

상기 화학식 8 내지 11에서,In Formulas 8 to 11,

Y1 내지 Y12, a 내지 c, R1 내지 R3는 각각 상기 화학식 1에서 정의한 바와 같다.Y 1 to Y 12 , a to c, and R 1 to R 3 are each as defined in Formula 1 above.

f는 0 내지 4의 정수이다. 이때, f가 0인 경우, 수소가 치환기 R6로 치환되지 않는 것을 의미한다. 또한, f가 1 내지 4의 정수인 경우, R6은 각각 독립적으로 중수소, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 이때 R6이 복수인 경우, 이들은 동일하거나 상이하다.f is an integer from 0 to 4; At this time, when f is 0, it means that hydrogen is not substituted with the substituent R 6 . In addition, when f is an integer of 1 to 4, R 6 is each independently deuterium, a C 1 ~ C 40 alkyl group, a C 6 ~ C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, and a C 6 ~ It is selected from the group consisting of C 60 arylamine groups, or may be combined with an adjacent group to form a condensed ring, wherein when R 6 is plural, they are the same or different.

이러한 화학식 1로 표시되는 화합물에서, 상기 Ar1 내지 Ar3, R1 내지 R3 중 적어도 하나는 하기 화학식 12로 표시되는 치환체일 수 있다.In the compound represented by Formula 1, at least one of Ar 1 to Ar 3 and R 1 to R 3 may be a substituent represented by Formula 12 below.

Figure 112015118508351-pat00014
Figure 112015118508351-pat00014

상기 화학식 12에서,In Formula 12,

*는 상기 화학식 1에 결합되는 부분을 의미한다.* means a part bonded to Formula 1 above.

L1은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택된다.L 1 is a single bond, or is selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms.

Z1 내지 Z5는 서로 동일하거나 상이하며, 각각 독립적으로 N 또는 C(R7)이며, 다만 Z1 내지 Z5 중 적어도 하나는 N이고, 이때 상기 R7가 복수인 경우, 이들은 서로 동일하거나 상이하다.Z 1 to Z 5 are the same as or different from each other, and are each independently N or C(R 7 ), provided that at least one of Z 1 to Z 5 is N, wherein, when R 7 is plural, they are the same as or It is different.

R7은 수소, 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있다.R 7 is hydrogen, deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, number of nuclear atoms 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~C 40 alkylsilyl group, C 6 ~C 60 arylsilyl group, C 1 ~C 40 alkylboron group, C 6 ~C 60 arylboron group, C 6 ~C 60 arylphosphine group, C 6 It is selected from the group consisting of ~C 60 arylphosphine oxide group and C 6 ~C 60 arylamine group, or may be combined with an adjacent group to form a condensed ring.

이때, 상기 L1의 아릴렌기 및 헤테로아릴렌기와, R7의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다.At this time, the arylene group and heteroarylene group of L 1 , an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group of R 7 , Arylsilyl group, alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl amine group are each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 Alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 6 ~ C 60 aryl group, heteroaryl having 5 to 60 nuclear atoms group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron At least one selected from the group consisting of a C 6 ~ C 60 arylboron group, a C 6 ~ C 60 arylphosphine group, a C 6 ~ C 60 arylphosphine oxide group, and a C 6 ~ C 60 arylamine group It may be substituted with a substituent, and in this case, when the substituent is plural, they may be the same as or different from each other.

상기 화학식 12로 표시되는 치환체는 하기 화학식 A1 내지 A15로 표시되는 치환체 중 어느 하나로 보다 구체화될 수 있다. 그러나, 이에 특별히 한정되지 않는다.The substituent represented by Chemical Formula 12 may be more specifically exemplified by any one of the substituents represented by Chemical Formulas A1 to A15. However, it is not particularly limited thereto.

Figure 112015118508351-pat00015
Figure 112015118508351-pat00015

상기 화학식 A1 내지 A15에서, L1 및 R7은 각각 상기 화학식 12에서 정의한 바와 같다.In Chemical Formulas A1 to A15, L 1 and R 7 are each as defined in Chemical Formula 12 above.

n은 0 내지 4의 정수이다. 이때, n이 0인 경우, 수소가 치환기 R8로 치환되지 않는 것을 의미한다. 또한, n이 1 내지 4의 정수일 경우, R8은 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 이때 R8이 복수인 경우, 이들은 서로 동일하거나 상이하다.n is an integer from 0 to 4; At this time, when n is 0, it means that hydrogen is not substituted with the substituent R 8 . In addition, when n is an integer of 1 to 4, R 8 is each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 arylboron group, It is selected from the group consisting of a C 6 ~ C 60 arylphosphine group, a C 6 ~ C 60 arylphosphine oxide group, and a C 6 ~ C 60 arylamine group, or may be combined with an adjacent group to form a condensed ring, At this time, when R 8 is plural, they are the same as or different from each other.

이때, 상기 R8의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다.In this case, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an arylsilyl group, an alkylboron group, and an arylboron of the R 8 Group, arylphosphine group, arylphosphine oxide group and arylamine group are each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group , C 3 ~ C 40 cycloalkyl group, 3 to 40 nuclear atoms heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group , C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 arylboron group , C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 arylphosphine oxide group and C 6 ~ C 60 may be substituted with one or more substituents selected from the group consisting of arylamine group, wherein the substituent is In case of plural, they may be the same as or different from each other.

이와 같이, 본 발명에 따른 화학식 1로 표시되는 화합물은 하기 예시되는 화합물 A-1 내지 A-10, B-1 내지 B-10, C-1 내지 C-10, D-1 내지 D-10, E-1 내지 E-10, F-1 내지 F-10 중 어느 하나로 보다 구체화될 수 있다. 그러나, 본 발명의 화학식 1로 표시되는 화합물이 하기 예시된 것들에 의해 한정되는 것은 아니다.As such, the compounds represented by Formula 1 according to the present invention are compounds A-1 to A-10, B-1 to B-10, C-1 to C-10, D-1 to D-10, Any one of E-1 to E-10 and F-1 to F-10 may be more specific. However, the compound represented by Formula 1 of the present invention is not limited by those exemplified below.

Figure 112015118508351-pat00016
Figure 112015118508351-pat00016

Figure 112015118508351-pat00017
Figure 112015118508351-pat00017

본 발명에서 "알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이러한 알킬의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyl" means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms. Examples of such alkyl include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.

본 발명에서 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이러한 알케닐의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkenyl" refers to a monovalent substituent derived from a straight-chain or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples of such alkenyl include, but are not limited to, vinyl, allyl, isopropenyl, and 2-butenyl.

본 발명에서 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이러한 알키닐의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkynyl" refers to a monovalent substituent derived from a straight-chain or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Examples of such alkynyl include, but are not limited to, ethynyl and 2-propynyl.

본 발명에서 "아릴"은 단독 고리 또는 2이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryl" means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms in a single ring or a combination of two or more rings. In addition, a form in which two or more rings are simply attached to each other (pendant) or condensed may be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.

본 발명에서 "헤테로아릴"은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 및 2-퓨라닐; N-이미다졸릴; 2-이속사졸릴; 2-피리디닐; 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heteroaryl" means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms. At this time, at least one carbon, preferably 1 to 3 carbons in the ring is substituted with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are simply attached to each other or condensed may be included, and furthermore, a form condensed with an aryl group may be included. Examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Polycyclics such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, and carbazolyl ring; and 2-furanyl; N-imidazolyl; 2-isoxazolyl; 2-pyridinyl; 2-pyrimidinyl and the like, but are not limited thereto.

본 발명에서 "아릴옥시"는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 6 내지 60의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryloxy" is a monovalent substituent represented by RO-, wherein R means an aryl having 6 to 60 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.

본 발명에서 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyloxy" is a monovalent substituent represented by R'O-, wherein R' means alkyl having 1 to 40 carbon atoms, and has a linear, branched or cyclic structure. can include Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy, and the like.

본 발명에서 "아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.In the present invention, "arylamine" means an amine substituted with an aryl having 6 to 60 carbon atoms.

본 발명에서 "시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

본 발명에서 "헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and one or more carbons in the ring, preferably 1 to 3 carbons, are N, O, S or a heteroatom such as Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.

본 발명에서 "알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴을 의미하고, "아릴실릴"은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미한다.In the present invention, “alkylsilyl” refers to silyl substituted with alkyl having 1 to 40 carbon atoms, and “arylsilyl” refers to silyl substituted with aryl having 6 to 60 carbon atoms.

본 발명에서 "알킬보론"은 탄소수 1 내지 40의 알킬로 치환된 보론을 의미하고, "아릴보론"은 탄소수 6 내지 60의 아릴로 치환된 보론을 의미한다.In the present invention, "alkyl boron" means boron substituted with alkyl having 1 to 40 carbon atoms, and "aryl boron" means boron substituted with aryl having 6 to 60 carbon atoms.

본 발명에서 "아릴포스핀"은 탄소수 6 내지 60의 아릴로 치환된 포스핀을 의미한다.In the present invention, "arylphosphine" means a phosphine substituted with an aryl having 6 to 60 carbon atoms.

본 발명에서 "축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, "condensed ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.

이와 같은 본 발명의 화학식 1로 표시되는 화합물은 하기 실시예의 합성과정을 참고하여 다양하게 합성할 수 있다.The compound represented by Chemical Formula 1 of the present invention can be variously synthesized by referring to the synthesis process in the following examples.

2. 유기 2. organic 전계electric field 발광 소자 light emitting element

본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention provides an organic electroluminescent device including the compound represented by Formula 1 above.

보다 구체적으로, 본 발명에 따른 유기 전계 발광 소자는 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화합물은 단독으로 사용되거나, 또는 2 이상이 혼합되어 사용될 수 있다.More specifically, the organic electroluminescent device according to the present invention includes an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and at least one of the one or more organic material layers. includes the compound represented by Formula 1 above. At this time, the above compounds may be used alone or in combination of two or more.

상기 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광 보조층, 발광층, 수명 개선층, 전자 수송층 및 전자 주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 구체적으로, 상기 화학식 1의 화합물을 포함하는 유기물층은 발광층, 전자 수송층, 정공 수송층, 수명 개선층인 것이 바람직하다.The one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, a lifespan improvement layer, an electron transport layer, and an electron injection layer, and at least one organic material layer among them is a compound represented by Formula 1 above. can include Specifically, the organic material layer containing the compound of Formula 1 is preferably a light emitting layer, an electron transport layer, a hole transport layer, or a lifespan improvement layer.

본 발명의 유기 전계 발광 소자의 발광층은 호스트 재료(바람직하게는, 인광 호스트 재료)를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 또한, 본 발명의 유기 전계 발광 소자의 발광층은 상기 화학식 1의 화합물 이외의 화합물을 호스트로 포함할 수 있다.The light emitting layer of the organic electroluminescent device of the present invention may include a host material (preferably, a phosphorescent host material), wherein the compound of Formula 1 may be included as the host material. In addition, the light emitting layer of the organic electroluminescent device of the present invention may include a compound other than the compound of Formula 1 as a host.

이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 비제한적인 예로 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공 수송층과 발광층 사이에는 발광 보조층이 개재(介在)될 수 있고, 상기 발광층과 전자수송층 사이에는 수명 개선층이 개재될 수 있다. 또한, 상기 전자 수송층 위에는 전자 주입층이 추가로 적층될 수 있다. 이러한 정공 주입층, 정공 수송층, 발광 보조층, 발광층, 수명 개선층, 전자 수송층 및 전자 주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 정공 수송층, 전자 수송층, 발광층, 수명 개선층 중 하나 이상이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 여기서, 본 발명의 유기 전계 발광 소자의 구조는 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.The structure of the organic electroluminescent device of the present invention is not particularly limited, but a non-limiting example may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and a cathode are sequentially stacked. . In this case, a light emitting auxiliary layer may be interposed between the hole transport layer and the light emitting layer, and a lifespan improvement layer may be interposed between the light emitting layer and the electron transport layer. In addition, an electron injection layer may be additionally stacked on the electron transport layer. At least one of the hole injection layer, the hole transport layer, the light emitting auxiliary layer, the light emitting layer, the lifespan improvement layer, the electron transport layer, and the electron injection layer may include the compound represented by Formula 1, and preferably the hole transport layer, the electron transport layer, At least one of the light emitting layer and the lifespan improvement layer may include the compound represented by Formula 1 above. Here, the structure of the organic electroluminescent device of the present invention may be a structure in which an insulating layer or an adhesive layer is inserted at the interface between the electrode and the organic material layer.

한편, 본 발명의 유기 전계 발광 소자는 상기 유기물층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는, 당업계에 공지된 재료 및 방법으로 유기물층 및 전극을 형성하여 제조할 수 있다.On the other hand, the organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode with materials and methods known in the art, except that at least one layer of the organic material layer contains the compound represented by Formula 1. there is.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이에 한정되지는 않는다.The organic layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution application method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명의 유기 전계 발광 소자 제조 시 사용되는 기판은 특별히 한정되지 않으나, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등을 사용할 수 있다.The substrate used in manufacturing the organic electroluminescent device of the present invention is not particularly limited, but may be a silicon wafer, quartz, glass plate, metal plate, plastic film or sheet.

또한, 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as an anode material, metals such as vanadium, chromium, copper, zinc, gold or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO2:Sb; conductive polymers such as polythiophene, poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDT), polypyrrole or polyaniline; and carbon black, but is not limited thereto.

또한, 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as the negative electrode material, metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or alloys thereof; and multi-layered materials such as LiF/Al or LiO2/Al, but are not limited thereto.

또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질을 사용할 수 있다.In addition, the hole injection layer, the hole transport layer, the electron injection layer, and the electron transport layer are not particularly limited, and conventional materials known in the art may be used.

이하, 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, the following examples are only to illustrate the present invention, and the present invention is not limited by the following examples.

[[ 준비예preparation example 1] One] EIAzEIAz -- 1 의1 of 합성 synthesis

<단계 1> 5-phenyl-5H-<Step 1> 5-phenyl-5H- dibenzo[b,f]azepinedibenzo[b,f]azepine 의 합성 synthesis of

Figure 112015118508351-pat00018
Figure 112015118508351-pat00018

질소 기류 하에서 5H-dibenzo[b,f]azepine (100 g, 517.5 mmol), iodobenzene (126.7 g, 621.0 mmol), Cu (16.4 g, 258.7 mmol), K2CO3 (143.0 g, 1,035.0 mmol) 및 nitrobenzene (1000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다.5H-dibenzo[b,f]azepine (100 g, 517.5 mmol), iodobenzene (126.7 g, 621.0 mmol), Cu (16.4 g, 258.7 mmol), K 2 CO 3 (143.0 g, 1,035.0 mmol) and Nitrobenzene (1000 ml) was mixed and stirred at 210 °C for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 농축하고 에탄올로 재결정 하여 5-phenyl-5H-dibenzo[b,f]azepine (100.4 g, 수율 72%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate, concentrated, and recrystallized with ethanol to obtain 5-phenyl-5H-dibenzo[b,f]azepine (100.4 g, yield 72%).

1H-NMR: δ 6.63-6.81 (m, 3H), 6.92 (d, 1H), 6.98 (d, 1H), 7.20 (d, 2H), 7.26-7.45 (m, 8H) 1 H-NMR: δ 6.63-6.81 (m, 3H), 6.92 (d, 1H), 6.98 (d, 1H), 7.20 (d, 2H), 7.26-7.45 (m, 8H)

<단계 2> 6-phenyl-6,10b-<Step 2> 6-phenyl-6,10b- dihydrodihydro -- 1aH1aH -- dibenzo[b,f]oxirenodibenzo[b,f]oxyreno [2,3-d][2,3-d] azepineazepine 의 합성 synthesis of

Figure 112015118508351-pat00019
Figure 112015118508351-pat00019

질소 기류 하에서 5-phenyl-5H-dibenzo[b,f]azepine (100.4 g, 372.6 mmol), meta-chloroperoxybenzoic acid(mCPBA) (77.2 g, 447.1 mmol), silica (200.7 g), NaOCl (200.7 g), acetonitrile(ACN) (1000 ml)를 혼합하고 80℃에서 2시간 동안 교반하였다.5-phenyl-5H-dibenzo[b,f]azepine (100.4 g, 372.6 mmol), meta- chloroperoxybenzoic acid (mCPBA) (77.2 g, 447.1 mmol), silica (200.7 g), NaOCl under a nitrogen stream (200.7 g) and acetonitrile (ACN) (1000 ml) were mixed and stirred at 80°C for 2 hours.

반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 에탄올로 재결정 하여 6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (84.0 g, 수율 79%)을 얻었다. After the reaction was completed, extraction was performed with methylene chloride, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was recrystallized with ethanol to obtain 6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (84.0 g, yield 79%).

1H-NMR: δ 4.31 (s, 2H), 6.63-6.81 (m, 3H), 7.24-7.53 (m, 10H) 1H -NMR: δ 4.31 (s, 2H), 6.63-6.81 (m, 3H), 7.24-7.53 (m, 10H)

<단계 3> 5-phenyl-5H-<Step 3> 5-phenyl-5H- dibenzo[b,f]azepindibenzo[b,f]azepin -10(11H)--10(11H)- one 의of one 합성 synthesis

Figure 112015118508351-pat00020
Figure 112015118508351-pat00020

질소 기류 하에서 6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (84.0 g, 294.3 mmol), lithium iodide(LiI) (47.3 g, 353.2 mmol) 및 chloroform(CHL) (840 ml)를 혼합하고 60℃에서 1시간 동안 교반하였다.6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (84.0 g, 294.3 mmol), lithium iodide(LiI) (47.3 g, 353.2 mmol) under nitrogen stream and chloroform (CHL) (840 ml) were mixed and stirred at 60°C for 1 hour.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 에탄올에서 재결정하여 5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (68.0 g, 수율 81%)을 얻었다. After the reaction was completed, it was extracted with ethyl acetate, then water was removed with MgSO 4 , and recrystallized from ethanol to obtain 5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (68.0 g, yield 81%) got

1H-NMR: δ 3.42 (d, 1H), 4.21 (d, 1H), 6.62-6.74 (m, 3H), 7.25-7.40 (m, 7H), 7.51-7.59 (m, 2H), 8.10 (d, 1H) 1H -NMR: δ 3.42 (d, 1H), 4.21 (d, 1H), 6.62-6.74 (m, 3H), 7.25-7.40 (m, 7H), 7.51-7.59 (m, 2H), 8.10 (d , 1H)

<단계 4> 5-phenyl-10,11-(5-<Step 4> 5-phenyl-10,11-(5- chlorochloro -1H--1H- indoleindole )-5H-)-5H- dibenzo[b,f]azepindibenzo[b,f]azepin 의 합성 synthesis of

Figure 112015118508351-pat00021
Figure 112015118508351-pat00021

질소 기류 하에서 5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (68.0 g, 238.4 mmol)과 (4-chlorophenyl)hydrazine (37.4 g, 262.3 mmol), acetic acid (700 ml)를 넣은 후 120℃에서 12시간 교반하였다.5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (68.0 g, 238.4 mmol) and (4-chlorophenyl)hydrazine under a nitrogen stream (37.4 g, 262.3 mmol) and acetic acid (700 ml) were added, followed by stirring at 120°C for 12 hours.

반응 종료 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 5-phenyl-10,11-(5-chloro-1H-indole)-5H-dibenzo[b,f]azepin (66.5 g, 수율 71 %)을 획득하였다.After completion of the reaction, extraction was performed with dichloromethane, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 3:1 (v/v)) to obtain 5-phenyl-10,11-(5-chloro-1H-indole)-5H-dibenzo[b ,f]azepin (66.5 g, yield 71%) was obtained.

1H-NMR : δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 6.98 (d, 1H), 7.16-7.20 (m, 4H), 7.38 (d, 1H), 7.54 (d, 1H), 7.68 (s, 1H), 8.83 (d, 1H), 11.36 (b, 1H) 1H -NMR: δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 6.98 (d, 1H), 7.16-7.20 (m, 4H), 7.38 (d, 1H), 7.54 (d , 1H), 7.68 (s, 1H), 8.83 (d, 1H), 11.36 (b, 1H)

<단계 5> 5-phenyl-10,11-(5-<Step 5> 5-phenyl-10,11-(5- chlorochloro -1-phenyl-1H--1-phenyl-1H- indoleindole )-5H-dibenzo[b,f]azepin 의 합성Synthesis of )-5H-dibenzo[b,f]azepin

Figure 112015118508351-pat00022
Figure 112015118508351-pat00022

질소 기류 하에서 5-phenyl-10,11-(5-chloro-1H-indole)-5H-dibenzo[b,f]azepin (66.5 g, 169.3 mmol), iodobenzene (41.4 g, 203.1 mmol), Cu (5.4 g, 84.6 mmol), K2CO3 (46.8 g, 338.6 mmol) 및 nitrobenzene (665 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다.5-phenyl-10,11-(5-chloro-1H-indole)-5H-dibenzo[b,f]azepin (66.5 g, 169.3 mmol), iodobenzene (41.4 g, 203.1 mmol), Cu (5.4 g, 84.6 mmol), K 2 CO 3 (46.8 g, 338.6 mmol) and nitrobenzene (665 ml) were mixed and stirred at 210° C. for 12 hours.

반응이 종결된 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 5:1 (v/v))로 정제하여 5-phenyl-10,11-(5-chloro-1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (58.0 g, 수율 73%)을 얻었다. After the reaction was completed, the mixture was extracted with dichloromethane, and MgSO 4 was added thereto and filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 5:1 (v/v)) to obtain 5-phenyl-10,11-(5-chloro-1-phenyl-1H-indole)-5H -dibenzo[b,f]azepin (58.0 g, yield 73%) was obtained.

1H-NMR: δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 7.16-7.20 (m, 5H), 7.45-7.69 (m, 8H), 8.83 (d, 1H) 1 H-NMR: δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 7.16-7.20 (m, 5H), 7.45-7.69 (m, 8H), 8.83 (d, 1H)

<단계 6> <Step 6> EIAzEIAz -- 1 의1 of 합성 synthesis

Figure 112015118508351-pat00023
Figure 112015118508351-pat00023

질소 기류 하에서 5-phenyl-10,11-(5-chloro-1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (57.8 g, 123.6 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (34.5 g, 135.9 mmol), Pd(dppf)Cl2 (10.8 g, 12.4 mmol), KOAc (34.9 g, 370.7 mmol) 및 1,4-Dioxane (600 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.5-phenyl-10,11-(5-chloro-1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (57.8 g, 123.6 mmol), 4,4,4',4 under nitrogen flow ',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (34.5 g, 135.9 mmol), Pd(dppf)Cl 2 (10.8 g, 12.4 mmol) , KOAc (34.9 g, 370.7 mmol) and 1,4-Dioxane (600 ml) were mixed and stirred at 130 °C for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 EIAz-1 (56.1 g, 수율 81 %)을 얻었다. After the reaction was completed, extraction was performed with ethyl acetate, water was removed with MgSO 4 , and purification was performed by column chromatography (Hexane:EA = 4:1 (v/v)) to obtain EIAz-1 (56.1 g, yield 81%). got it

1H-NMR: δ 1.24 (s, 12H), 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 7.16-7.20 (m, 4H), 7.45-7.60 (m, 8H), 7.71 (d, 1h), 8.83 (d, 1H) 1H -NMR: δ 1.24 (s, 12H), 6.63-6.69 (m, 4H), 6.81-6.87 (m, 3H), 7.16-7.20 (m, 4H), 7.45-7.60 (m, 8H), 7.71 (d, 1h), 8.83 (d, 1H)

[[ 준비예preparation example 2] 2] EIAzEIAz -- 2 의2 of 합성 synthesis

<단계 1> 1-(4-<Step 1> 1-(4- chlorophenylchlorophenyl )-1H-)-1H- indoleindole 의 합성 synthesis of

Figure 112015118508351-pat00024
Figure 112015118508351-pat00024

질소 기류 하에서 1H-indole (100g, 854.0 mmol), 1-chloro-4-iodobenzene (244.3 g, 1024.8 mmol), Cu (27.2 g, 427.0 mmol), K2CO3 (236.1 g, 1.70 mol) 및 nitrobenzene (3000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다.1H-indole (100 g, 854.0 mmol), 1-chloro-4-iodobenzene (244.3 g, 1024.8 mmol), Cu (27.2 g, 427.0 mmol), K 2 CO 3 (236.1 g, 1.70 mol) and nitrobenzene under a nitrogen stream. (3000 ml) and stirred at 210° C. for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 1-(4-chlorophenyl)-1H-indole (163.3 g, 수율 84%)을 얻었다. After the reaction was completed, it was extracted with ethyl acetate, then water was removed with MgSO 4 , and purified by column chromatography (Hexane:EA = 8:1 (v/v)) to obtain 1-(4-chlorophenyl)-1H-indole ( 163.3 g, yield 84%) was obtained.

1H-NMR: δ 6.52 (d, 1H), 6.87 (dd, 1H), 7.33-7.37 (m, 3H), 7.49 (d, 2H), 7.60 (d, 1H), 7.93-7.94 (m, 2H) 1H -NMR: δ 6.52 (d, 1H), 6.87 (dd, 1H), 7.33-7.37 (m, 3H), 7.49 (d, 2H), 7.60 (d, 1H), 7.93-7.94 (m, 2H) )

<단계 2> 2-<Step 2> 2- chlorochloro -5H--5H- dibenzo[b,f]azepinedibenzo[b,f]azepine 의 합성 synthesis of

Figure 112015118508351-pat00025
Figure 112015118508351-pat00025

질소 기류 하에서 1-(4-chlorophenyl)-1H-indole (163.3g, 717.4 mmol), polyphosphoric acid(PPA) (817 g)를 혼합하고 100℃에서 12시간 동안 교반하였다.1-(4-chlorophenyl)-1H-indole (163.3g, 717.4 mmol) and polyphosphoric acid (PPA) (817 g) were mixed under a nitrogen stream and stirred at 100°C for 12 hours.

반응이 종결된 후 물에서 추출한 다음 여과하여 2-chloro-5H-dibenzo[b,f]azepine (49 g, 수율 30%)을 얻었다. After the reaction was completed, the mixture was extracted from water and filtered to obtain 2-chloro-5H-dibenzo[b,f]azepine (49 g, yield 30%).

1H-NMR: δ 6.57 (d, 1H), 6.81 (dd, 1H), 6.99-7.09 (m, 4H), 7.17 (s, 1H), 7.25 (d, 1H), 8.21 (d, 1H), 8.42 (b, 1H) 1H -NMR: δ 6.57 (d, 1H), 6.81 (dd, 1H), 6.99-7.09 (m, 4H), 7.17 (s, 1H), 7.25 (d, 1H), 8.21 (d, 1H), 8.42 (b, 1H)

<단계 3> 2-<Step 3> 2- chlorochloro -5-phenyl-5H--5-phenyl-5H- dibenzo[b,f]azepinedibenzo[b,f]azepine 의 합성 synthesis of

Figure 112015118508351-pat00026
Figure 112015118508351-pat00026

질소 기류 하에서 2-chloro-5H-dibenzo[b,f]azepine (49 g, 215.2 mmol), iodobenzene (52.7 g, 258.1 mmol), Cu (6.8 g, 107.6 mmol), K2CO3 (59.5 g, 430 mmol) 및 nitrobenzene (1000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다.2-chloro-5H-dibenzo[b,f]azepine (49 g, 215.2 mmol), iodobenzene (52.7 g, 258.1 mmol), Cu (6.8 g, 107.6 mmol), K 2 CO 3 (59.5 g, 430 mmol) and nitrobenzene (1000 ml) were mixed and stirred at 210 °C for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-chloro-5-phenyl-5H-dibenzo[b,f]azepine (52.3 g, 수율 80%)을 얻었다. After the reaction was completed, extraction was performed with ethyl acetate, water was removed with MgSO 4 , and purified by column chromatography (Hexane:EA = 7:1 (v/v)) to obtain 2-chloro-5-phenyl-5H-dibenzo[ b,f]azepine (52.3 g, yield 80%) was obtained.

1H-NMR: δ 6.57-6.63 (m, 4H), 6.80-6.81 (m, 2H), 6.99-7.09 (m, 4H), 7.17-7.25 (m, 4H) 1 H-NMR: δ 6.57-6.63 (m, 4H), 6.80-6.81 (m, 2H), 6.99-7.09 (m, 4H), 7.17-7.25 (m, 4H)

<단계 4> 3-<Step 4> 3- chlorochloro -6-phenyl-6,10b--6-phenyl-6,10b- dihydrodihydro -- 1aH1aH -- dibenzo[b,f]oxirenodibenzo[b,f]oxyreno [2,3-d]azepine 의 합성Synthesis of [2,3-d]azepine

Figure 112015118508351-pat00027
Figure 112015118508351-pat00027

질소 기류 하에서 2-chloro-5-phenyl-5H-dibenzo[b,f]azepine (52.3 g, 172.1 mmol), meta-chloroperoxybenzoic acid (35.6 g, 206.5 mmol), silica (104.6 g), NaOCl (104.6 g), acetonitrile (550 ml)를 혼합하고 80℃에서 2시간 동안 교반하였다.2-chloro-5-phenyl-5H-dibenzo[b,f]azepine (52.3 g, 172.1 mmol), meta- chloroperoxybenzoic acid (35.6 g, 206.5 mmol), silica (104.6 g), NaOCl under a nitrogen stream (104.6 g) and acetonitrile (550 ml) were mixed and stirred at 80°C for 2 hours.

반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 에탄올로 재결정 하여 3-chloro-6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (45.1 g, 수율 82%)을 얻었다. After the reaction was completed, extraction was performed with methylene chloride, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was recrystallized with ethanol to obtain 3-chloro-6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (45.1 g, yield 82%) got

1H-NMR: δ 4.20 (s, 2H), 6.63-6.56 (m, 4H), 6.74-6.81 (m, 2H), 7.11-7.20 (m, 5H), 7.31 (s, 1H) 1 H-NMR: δ 4.20 (s, 2H), 6.63-6.56 (m, 4H), 6.74-6.81 (m, 2H), 7.11-7.20 (m, 5H), 7.31 (s, 1H)

<단계 5> 2-<Step 5> 2- chlorochloro -5-phenyl-5H--5-phenyl-5H- dibenzo[b,f]azepindibenzo[b,f]azepin -10(11H)--10(11H)- one 의of one 합성 synthesis

Figure 112015118508351-pat00028
Figure 112015118508351-pat00028

질소 기류 하에서 3-chloro-6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (45.1 g, 141.1 mmol), lithium iodide (22.7 g, 169.3 mmol) 및 chloroform (500 ml)를 혼합하고 60℃에서 1시간 동안 교반하였다.3-chloro-6-phenyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]azepine (45.1 g, 141.1 mmol), lithium iodide (22.7 g, 169.3 mmol) under nitrogen stream ) and chloroform (500 ml) were mixed and stirred at 60° C. for 1 hour.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 에탄올에서 재결정하여 2-chloro-5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (38.4 g, 수율 85%)을 얻었다. After the reaction was completed, it was extracted with ethyl acetate, then water was removed with MgSO 4 , and recrystallized from ethanol to obtain 2-chloro-5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (38.4 g, Yield 85%) was obtained.

1H-NMR: δ 3.80 (s, 2H), 6.45 (d, 1H), 6.63 (d, 2H), 6.74-6.81 (m, 2H), 6.92 (dd, 1H), 7.05 (d, 1H), 7.18-7.20 (m, 3H), 7.39 (dd, 1H), 7.54 (d, 1H) 1H -NMR: δ 3.80 (s, 2H), 6.45 (d, 1H), 6.63 (d, 2H), 6.74-6.81 (m, 2H), 6.92 (dd, 1H), 7.05 (d, 1H), 7.18-7.20 (m, 3H), 7.39 (dd, 1H), 7.54 (d, 1H)

<단계 6> 2-<Step 6> 2- chlorochloro -5-phenyl-10,11-(1-phenyl-1H--5-phenyl-10,11-(1-phenyl-1H- indoleindole )-5H-dibenzo[b,f]azepin 의 합성Synthesis of )-5H-dibenzo[b,f]azepin

Figure 112015118508351-pat00029
Figure 112015118508351-pat00029

질소 기류 하에서 2-chloro-5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (38.4 g, 120.0 mmol)과 1,1-diphenylhydrazine (24.3 g, 131.9 mmol), acetic acid (400 ml)를 넣은 후 120℃에서 12시간 교반하였다.2-chloro-5-phenyl-5H-dibenzo[b,f]azepin-10(11H)-one (38.4 g, 120.0 mmol) and 1,1-diphenylhydrazine (24.3 g, 131.9 mmol), acetic acid under a nitrogen stream (400 ml) was added and stirred at 120°C for 12 hours.

반응 종료 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 2-chloro-5-phenyl-10,11-(1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (42.8 g, 수율 76 %)을 획득하였다. After completion of the reaction, extraction was performed with dichloromethane, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 3:1 (v/v)) to obtain 2-chloro-5-phenyl-10,11-(1-phenyl-1H-indole)-5H -dibenzo[b,f]azepin (42.8 g, yield 76%) was obtained.

1H-NMR : δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 4H), 7.42-7.58 (m, 7H), 7.71-7.76 (m, 2H), 8.17 (d, 1H), 8.83 (d, 1H) 1 H-NMR: δ 6.63-6.69 (m, 4H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 4H), 7.42-7.58 (m, 7H), 7.71-7.76 (m, 2H) , 8.17 (d, 1H), 8.83 (d, 1H)

<단계 7> <Step 7> EIAzEIAz -- 2 의2 of 합성 synthesis

Figure 112015118508351-pat00030
Figure 112015118508351-pat00030

질소 기류 하에서 2-chloro-5-phenyl-10,11-(1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (42.8 g, 91.1 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (25.5 g, 100.3 mmol), Pd(dppf)Cl2 (8.0 g, 9.1 mmol), KOAc (25.7 g, 273.5 mmol) 및 1,4-Dioxane (400 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.2-chloro-5-phenyl-10,11-(1-phenyl-1H-indole)-5H-dibenzo[b,f]azepin (42.8 g, 91.1 mmol), 4,4,4',4 under nitrogen flow ',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (25.5 g, 100.3 mmol), Pd(dppf)Cl 2 (8.0 g, 9.1 mmol) , KOAc (25.7 g, 273.5 mmol) and 1,4-Dioxane (400 ml) were mixed and stirred at 130 °C for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 EIAz-2 (39.9 g, 수율 78 %)을 얻었다. After the reaction was completed, it was extracted with ethyl acetate, then water was removed with MgSO 4 , and purified by column chromatography (Hexane:EA = 4:1 (v/v)) to obtain EIAz-2 (39.9 g, yield 78%). got it

1H-NMR: δ 1.24 (s, 12H), 6.63-6.69 (m, 4H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.41-7.58 (m, 9H), 7.71 (d, 1H), 8.17 (d, 1H), 8.83 (d, 1H) 1H -NMR: δ 1.24 (s, 12H), 6.63-6.69 (m, 4H), 6.81-6.87 (m, 2H), 7.16-7.20 (m, 3H), 7.41-7.58 (m, 9H), 7.71 (d, 1H), 8.17 (d, 1H), 8.83 (d, 1H)

[[ 준비예preparation example 3] 3] EIAzEIAz -- 3 의3 of 합성 synthesis

<단계 1> 5-H-<Step 1> 5-H- Dibenzo[a,d]cyclohepteneDibenzo[a,d]cycloheptene 의 합성 synthesis of

Figure 112015118508351-pat00031
Figure 112015118508351-pat00031

질소 기류 하에서 5-dibenzosuberenone (100g, 484.9 mmol), N2H2 ·H2O (830 mL)를 혼합하고 반응용기를 밀봉한 뒤 180℃에서 15시간 동안 교반하였다.5-dibenzosuberenone (100g, 484.9 mmol) and N 2 H 2 · H 2 O (830 mL) were mixed under a nitrogen stream, and the reaction vessel was sealed and stirred at 180°C for 15 hours.

반응이 종결된 후 상온으로 냉각하고, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 메탄올로 석출하여 5-H-Dibenzo[a,d]cycloheptene (69.9 g, 수율 75%)을 얻었다. After the reaction was completed, the mixture was cooled to room temperature, extracted with ethyl acetate, dried with MgSO 4 , and precipitated with methanol to obtain 5-H-Dibenzo[a,d]cycloheptene (69.9 g, yield 75%).

1H-NMR: δ 3.51 (s, 2H), 6.99 (s, 2H), 7.07 (d, 2H), 7.18 (dd, 2H), 7.26 (dd, 2H), 7.38 (d, 2H) 1 H-NMR: δ 3.51 (s, 2H), 6.99 (s, 2H), 7.07 (d, 2H), 7.18 (dd, 2H), 7.26 (dd, 2H), 7.38 (d, 2H)

<단계 2> 5,5-<Step 2> 5,5- dimethyldimethyl -5-H--5-H- Dibenzo[a,d]cyclohepteneDibenzo[a,d]cycloheptene 의 합성 synthesis of

Figure 112015118508351-pat00032
Figure 112015118508351-pat00032

질소 기류 하에서 5-H-Dibenzo[a,d]cycloheptene (69.9g, 363.7 mmol), DMSO (1000 mL)를 혼합하고, methyl iodide(MeI) (103.2g, 727.3mmol), KI (6.64g, 40.0 mmol)를 적가한 뒤 반응 온도를 0℃ 까지 낮춘다. KOH (85.7g, 1,527.3 mmol)를 가하고 0℃ 에서 15분간 교반 한 후 상온으로 승온하여 15시간 교반하였다. 다시 methyl iodide (34.6g, 243.6 mmol)를 넣은 후, 60℃ 에서 7시간 교반하였다.5-H-Dibenzo[a,d]cycloheptene (69.9g, 363.7 mmol) and DMSO (1000 mL) were mixed under a nitrogen stream, and methyl iodide (MeI) (103.2g, 727.3mmol), KI (6.64g, 40.0 mmol) was added dropwise, and the reaction temperature was lowered to 0°C. After adding KOH (85.7g, 1,527.3 mmol) and stirring at 0°C for 15 minutes, the temperature was raised to room temperature and stirred for 15 hours. After adding methyl iodide (34.6g, 243.6 mmol) again, the mixture was stirred at 60°C for 7 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptene (51.3 g, 수율 62%)을 얻었다. After the reaction was completed, extraction was performed with ethyl acetate, water was removed with MgSO 4 , and 5,5-dimethyl-5-H-Dibenzo[ a,d] cycloheptene (51.3 g, yield 62%) was obtained.

1H-NMR: δ 1.72 (s, 6H), 6.99 (s, 2H), 7.22-7.30 (m, 6H), 7.42 (d, 2H) 1H -NMR: δ 1.72 (s, 6H), 6.99 (s, 2H), 7.22-7.30 (m, 6H), 7.42 (d, 2H)

<단계 3> 6,6-<Step 3> 6,6- dimethyldimethyl -6,10b--6,10b- dihydrodihydro -- 1aH1aH -- dibenzo[b,f]oxirenodibenzo[b,f]oxyreno [2,3-d]cycloheptene 의 합성Synthesis of [2,3-d]cycloheptene

Figure 112015118508351-pat00033
Figure 112015118508351-pat00033

질소 기류 하에서 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptene (51.3 g, 225.5 mmol), meta-chloroperoxybenzoic acid (46.7 g, 270.6 mmol), silica (102.7 g), NaOCl (102.7 g), acetonitrile (513.4 ml)를 혼합하고 80℃에서 2시간 동안 교반하였다.5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptene (51.3 g, 225.5 mmol), meta- chloroperoxybenzoic acid (46.7 g, 270.6 mmol), silica (102.7 g), NaOCl under a nitrogen stream (102.7 g) and acetonitrile (513.4 ml) were mixed and stirred at 80°C for 2 hours.

반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 에탄올로 재결정 하여 6,6-dimethyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]cycloheptene (41.6 g, 수율 78%)을 얻었다. After the reaction was completed, extraction was performed with methylene chloride, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was recrystallized with ethanol to obtain 6,6-dimethyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]cycloheptene (41.6 g, yield 78%) .

1H-NMR: δ 1.72 (s, 6H), 4.20 (s, 2H) 6.99 (s, 2H), 7.20-7.30 (m, 6H), 7.59 (d, 2H) 1H -NMR: δ 1.72 (s, 6H), 4.20 (s, 2H) 6.99 (s, 2H), 7.20-7.30 (m, 6H), 7.59 (d, 2H)

<단계 4> 5,5-<Step 4> 5,5- dimethyldimethyl -5-H--5-H- Dibenzo[a,d]cycloheptaneDibenzo[a,d]cycloheptane -10(11H)--10(11H)- one 의of one 합성 synthesis

Figure 112015118508351-pat00034
Figure 112015118508351-pat00034

질소 기류 하에서 6,6-dimethyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]cycloheptene (41.6 g, 175.9 mmol), lithium iodide (28.2 g, 211.0 mmol) 및 chloroform (500 ml)를 혼합하고 60℃에서 1시간 동안 교반하였다.6,6-dimethyl-6,10b-dihydro-1aH-dibenzo[b,f]oxireno[2,3-d]cycloheptene (41.6 g, 175.9 mmol), lithium iodide (28.2 g, 211.0 mmol) and chloroform (500 ml) was mixed and stirred at 60 °C for 1 hour.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 에탄올에서 재결정하여 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 수율 75%)을 얻었다. After the reaction was completed, it was extracted with ethyl acetate, then water was removed with MgSO 4 , and recrystallized from ethanol to obtain 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, Yield 75%) was obtained.

1H-NMR: δ 1.72 (s, 6H), 3.81 (s, 2H) 7.18 (dd, 1H), 7.38-7.44 (m, 4H), 7.54-7.56 (m, 2H), 7.86 (d, 1H) 1H -NMR: δ 1.72 (s, 6H), 3.81 (s, 2H) 7.18 (dd, 1H), 7.38-7.44 (m, 4H), 7.54-7.56 (m, 2H), 7.86 (d, 1H)

<단계 5> <Step 5> EIAzEIAz -- 3 의3 of 합성 synthesis

Figure 112015118508351-pat00035
Figure 112015118508351-pat00035

질소 기류 하에서 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol)과 phenylhydrazine (15.7 g, 145.1 mmol), acetic acid (350 ml)를 넣은 후 120℃에서 12시간 교반하였다.5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol), phenylhydrazine (15.7 g, 145.1 mmol), and acetic acid (350 ml) under a nitrogen stream. After putting the mixture was stirred at 120 ° C. for 12 hours.

반응 종료 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 EIAz-3 (26.5 g, 수율 65 %)을 획득하였다. After completion of the reaction, extraction was performed with dichloromethane, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 3:1 (v/v)) to obtain EIAz-3 (26.5 g, yield 65%).

1H-NMR : δ 1.72 (s, 6H), 7.06-7.08 (m, 2H), 7.33-7.44 (m, 7H), 7.56-7.60 (m, 2H), 7.71 (d, 1H), 11.36 (b, 1H) 1H -NMR: δ 1.72 (s, 6H), 7.06-7.08 (m, 2H), 7.33-7.44 (m, 7H), 7.56-7.60 (m, 2H), 7.71 (d, 1H), 11.36 (b) , 1H)

[[ 준비예preparation example 4] 4] EIAzEIAz -4의 합성Synthesis of -4

<단계 1> 내지 <단계 4> <Step 1> to <Step 4>

준비예 3의 <단계 1> 내지 <단계 4>와 동일한 과정을 수행하였다.The same procedures as <Step 1> to <Step 4> of Preparation Example 3 were performed.

<단계 5> <Step 5> EIAzEIAz -- 4 의4 of 합성 synthesis

Figure 112015118508351-pat00036
Figure 112015118508351-pat00036

질소 기류 하에서 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol)과 naphthalen-1-ylhydrazine (23.0 g, 145.1 mmol), acetic acid (350 ml)를 넣은 후 120℃에서 12시간 교반하였다.5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol) and naphthalen-1-ylhydrazine (23.0 g, 145.1 mmol), acetic acid under a nitrogen atmosphere (350 ml) was added and stirred at 120°C for 12 hours.

반응 종료 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 EIAz-4 (26.1 g, 수율 55 %)을 획득하였다. After completion of the reaction, extraction was performed with dichloromethane, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 3:1 (v/v)) to obtain EIAz-4 (26.1 g, yield 55%).

1H-NMR : δ 1.72 (s, 6H), 7.33-7.36 (m, 6H), 7.60-7.71 (m, 6H), 8.16 (d, 1H), 8.51 (d, 1H), 11.36 (b, 1H) 1H -NMR: δ 1.72 (s, 6H), 7.33-7.36 (m, 6H), 7.60-7.71 (m, 6H), 8.16 (d, 1H), 8.51 (d, 1H), 11.36 (b, 1H) )

[[ 준비예preparation example 5] 5] EIAzEIAz -5의 합성Synthesis of -5

<단계 1> 내지 <단계 4> <Step 1> to <Step 4>

준비예 3의 <단계 1> 내지 <단계 4>와 동일한 과정을 수행하였다.The same procedures as <Step 1> to <Step 4> of Preparation Example 3 were performed.

<단계 5> 5,5-<Step 5> 5,5- dimethyldimethyl -10,11-(5--10,11-(5- chlorochloro -1H--1H- indoleindole )-5-H-Dibenzo[a,d]cycloheptene 의 합성Synthesis of )-5-H-Dibenzo[a,d]cycloheptene

Figure 112015118508351-pat00037
Figure 112015118508351-pat00037

질소 기류 하에서 5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol)과 (4-chlorophenyl)hydrazine (20.7 g, 145.1 mmol), acetic acid (350 ml)를 넣은 후 120℃에서 12시간 교반하였다.5,5-dimethyl-5-H-Dibenzo[a,d]cycloheptane-10(11H)-one (31.2 g, 131.2 mmol) and (4-chlorophenyl)hydrazine (20.7 g, 145.1 mmol), acetic acid under a nitrogen stream After adding acid (350 ml), the mixture was stirred at 120°C for 12 hours.

반응 종료 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 5,5-dimethyl-10,11-(5-chloro-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (26.8 g, 수율 59 %)을 획득하였다. After completion of the reaction, extraction was performed with dichloromethane, MgSO 4 was added, and the mixture was filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 4:1 (v/v)) to obtain 5,5-dimethyl-10,11-(5-chloro-1H-indole)-5-H -Dibenzo[a,d]cycloheptene (26.8 g, yield 59%) was obtained.

1H-NMR : δ 1.72 (s, 6H), 6.98 (d, 1H), 7.33-7.38 (m, 7H), 7.60 (d, 1H), 7.68-7.71 (m, 2H), 11.36 (b, 1H) 1H -NMR: δ 1.72 (s, 6H), 6.98 (d, 1H), 7.33-7.38 (m, 7H), 7.60 (d, 1H), 7.68-7.71 (m, 2H), 11.36 (b, 1H) )

<단계 6> 5,5-<Step 6> 5,5- dimethyldimethyl -10,11-(5--10,11-(5- chlorochloro -1-phenyl-1H--1-phenyl-1H- indoleindole )-5-H-Dibenzo[a,d]cycloheptene 의 합성Synthesis of )-5-H-Dibenzo[a,d]cycloheptene

Figure 112015118508351-pat00038
Figure 112015118508351-pat00038

질소 기류 하에서 5,5-dimethyl-10,11-(5-chloro-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (26.8 g, 77.8 mmol), iodobenzene (19.2 g, 93.4 mmol), Cu (2.5 g, 38.9 mmol), K2CO3 (21.5 g, 155.6 mmol) 및 nitrobenzene (300 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다.5,5-dimethyl-10,11-(5-chloro-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (26.8 g, 77.8 mmol), iodobenzene (19.2 g, 93.4 mmol) under nitrogen stream , Cu (2.5 g, 38.9 mmol), K 2 CO 3 (21.5 g, 155.6 mmol) and nitrobenzene (300 ml) were mixed and stirred at 210 °C for 12 hours.

반응이 종결된 후 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 5,5-dimethyl-10,11-(5-chloro-1-phenyl-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (24.5 g, 수율 75%)을 얻었다. After the reaction was completed, the mixture was extracted with dichloromethane, and MgSO 4 was added thereto and filtered. After removing the solvent from the obtained organic layer, it was purified by column chromatography (Hexane:MC = 4:1 (v/v)) to obtain 5,5-dimethyl-10,11-(5-chloro-1-phenyl-1H-indole) -5-H-Dibenzo[a,d]cycloheptene (24.5 g, yield 75%) was obtained.

1H-NMR: δ 1.72 (s, 6H), 7.18 (d, 1H), 7.33-7.38 (m, 6H), 7.45-7.71 (m, 9H) 1H -NMR: δ 1.72 (s, 6H), 7.18 (d, 1H), 7.33-7.38 (m, 6H), 7.45-7.71 (m, 9H)

<단계 7> <Step 7> EIAzEIAz -- 5 의5 of 합성 synthesis

Figure 112015118508351-pat00039
Figure 112015118508351-pat00039

질소 기류 하에서 5,5-dimethyl-10,11-(5-chloro-1-phenyl-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (24.5 g, 58.4 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (16.3 g, 64.2 mmol), Pd(dppf)Cl2 (5.1 g, 5.8 mmol), KOAc (16.5 g, 175.1 mmol) 및 1,4-Dioxane (200 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.5,5-dimethyl-10,11-(5-chloro-1-phenyl-1H-indole)-5-H-Dibenzo[a,d]cycloheptene (24.5 g, 58.4 mmol), 4,4, 4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (16.3 g, 64.2 mmol), Pd(dppf)Cl 2 (5.1 g , 5.8 mmol), KOAc (16.5 g, 175.1 mmol) and 1,4-Dioxane (200 ml) were mixed and stirred at 130 °C for 12 hours.

반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여 EIAz-5 (23.3 g, 수율 78 %)을 얻었다. After the reaction was completed, extraction was performed with ethyl acetate, water was removed with MgSO 4 , and purification was performed by column chromatography (Hexane:EA = 5:1 (v/v)) to obtain EIAz-5 (23.3 g, yield 78%). got it

1H-NMR: δ 1.24 (s, 12H), 1.72 (s, 6H), 7.33-7.36 (m, 6H), 7.45-7.50 (m. 3H), 7.58-7.60 (m, 5H), 7.71-7.72 (m, 2H) 1H -NMR: δ 1.24 (s, 12H), 1.72 (s, 6H), 7.33-7.36 (m, 6H), 7.45-7.50 (m. 3H), 7.58-7.60 (m, 5H), 7.71-7.72 (m, 2H)

[[ 합성예synthesis example 1] A-1의 합성 1] Synthesis of A-1

Figure 112015118508351-pat00040
Figure 112015118508351-pat00040

질소 기류 하에서 준비예 1에서 합성된 EIAz-1 (3.8 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 A-1 (3.5 g, 수율 71%)을 얻었다.EIAz-1 (3.8 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd (PPh 3 ) synthesized in Preparation Example 1 under a nitrogen stream 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110° C. for 5 hours. After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound A-1 (3.5 g, yield 71%).

Mass (이론치: 740.89, 측정치: 740 g/mol) Mass (Theory: 740.89, Measured: 740 g/mol)

[[ 합성예synthesis example 2] A-2의 합성 2] Synthesis of A-2

Figure 112015118508351-pat00041
Figure 112015118508351-pat00041

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-2 (3.3 g, 수율 73%)를 얻었다.Synthesis except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The same procedure as in Example 1 was performed to obtain the target compound A-2 (3.3 g, yield 73%).

Mass (이론치: 665.78, 측정치: 665 g/mol)Mass (Theory: 665.78, Measured: 665 g/mol)

[[ 합성예synthesis example 3] A-3의 합성 3] Synthesis of A-3

Figure 112015118508351-pat00042
Figure 112015118508351-pat00042

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-3 (3.8 g, 수율 77%)을 얻었다.Same as Synthesis Example 1 except for using 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The process was performed to obtain the target compound A-3 (3.8 g, yield 77%).

Mass (이론치: 740.89, 측정치: 740 g/mol)Mass (Theory: 740.89, Measured: 740 g/mol)

[[ 합성예synthesis example 4] A-4의 합성 4] Synthesis of A-4

Figure 112015118508351-pat00043
Figure 112015118508351-pat00043

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-4 (3.5 g, 수율 70%)를 얻었다.It is recommended to use 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 1 was performed to obtain the target compound A-4 (3.5 g, yield 70%).

Mass (이론치: 741.88, 측정치: 741 g/mol)Mass (Theory: 741.88, Measured: 741 g/mol)

[[ 합성예synthesis example 5] A-5의 합성 5] Synthesis of A-5

Figure 112015118508351-pat00044
Figure 112015118508351-pat00044

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-5 (3.6 g, 수율 72%)를 얻었다.It is recommended to use 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. A target compound, A-5 (3.6 g, yield 72%) was obtained by performing the same process as in Synthesis Example 1 except for the above.

Mass (이론치: 741.88, 측정치: 741 g/mol)Mass (Theory: 741.88, Measured: 741 g/mol)

[[ 합성예synthesis example 6] A-6의 합성 6] Synthesis of A-6

Figure 112015118508351-pat00045
Figure 112015118508351-pat00045

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-6 (3.7 g, 수율 68%)을 얻었다.It is recommended to use 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 1 was performed to obtain the target compound A-6 (3.7 g, yield 68%).

Mass (이론치: 816.98, 측정치: 816 g/mol)Mass (Theory: 816.98, Measured: 816 g/mol)

[[ 합성예synthesis example 7] A-7의 합성 7] Synthesis of A-7

Figure 112015118508351-pat00046
Figure 112015118508351-pat00046

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-7 (4.3 g, 수율 79%)을 얻었다.2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine , 8.0 mmol), but the same procedure as in Synthesis Example 1 was performed to obtain the target compound A-7 (4.3 g, yield 79%).

Mass (이론치: 817.97, 측정치: 817 g/mol)Mass (Theory: 817.97, Measured: 817 g/mol)

[[ 합성예synthesis example 8] A-8의 합성 8] Synthesis of A-8

Figure 112015118508351-pat00047
Figure 112015118508351-pat00047

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-8 (3.6 g, 수율 65%)을 얻었다.2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine ) The target compound A-8 (3.6 g, yield 65%) was obtained by performing the same procedure as in Synthesis Example 1 except for using.

Mass (이론치: 817.97, 측정치: 817 g/mol)Mass (Theory: 817.97, Measured: 817 g/mol)

[[ 합성예synthesis example 9] A-9의 합성 9] Synthesis of A-9

Figure 112015118508351-pat00048
Figure 112015118508351-pat00048

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-9 (1.9 g, 수율 67%)을 얻었다.The target compound was obtained by performing the same procedure as in Synthesis Example 1, except that 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Phosphorus A-9 (1.9 g, yield 67%) was obtained.

Mass (이론치: 638.75, 측정치: 638 g/mol)Mass (Theory: 638.75, Measured: 638 g/mol)

[[ 합성예synthesis example 10] A-10의 합성 10] Synthesis of A-10

Figure 112015118508351-pat00049
Figure 112015118508351-pat00049

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-10 (3.5 g, 수율 70%)을 얻었다.The same procedure as in Synthesis Example 1 was performed except for using 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Compound A-10 (3.5 g, yield 70%) was obtained.

Mass (이론치: 736.9, 측정치: 736 g/mol)Mass (Theory: 736.9, Measured: 736 g/mol)

[[ 합성예synthesis example 11] B-1의 합성 11] Synthesis of B-1

Figure 112015118508351-pat00050
Figure 112015118508351-pat00050

질소 기류 하에서 준비예 2에서 합성된 EIAz-2 (3.8 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 B-1 (3.2 g, 수율 65%)을 얻었다.EIAz-2 (3.8 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd (PPh 3 ) synthesized in Preparation Example 2 under a nitrogen stream 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110° C. for 5 hours. After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound B-1 (3.2 g, yield 65%).

Mass (이론치: 740.89, 측정치: 740 g/mol) Mass (Theory: 740.89, Measured: 740 g/mol)

[[ 합성예synthesis example 12] B-2의 합성 12] Synthesis of B-2

Figure 112015118508351-pat00051
Figure 112015118508351-pat00051

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-2 (3.1 g, 수율 70%)를 얻었다.Synthesis except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The same procedure as in Example 11 was performed to obtain the target compound B-2 (3.1 g, yield 70%).

Mass (이론치: 665.78, 측정치: 665 g/mol)Mass (Theory: 665.78, Measured: 665 g/mol)

[[ 합성예synthesis example 13] B-3의 합성 13] Synthesis of B-3

Figure 112015118508351-pat00052
Figure 112015118508351-pat00052

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-3 (3.7 g, 수율 75%)을 얻었다.Same as Synthesis Example 11 except for using 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The process was performed to obtain the target compound B-3 (3.7 g, yield 75%).

Mass (이론치: 740.89, 측정치: 740 g/mol)Mass (Theory: 740.89, Measured: 740 g/mol)

[[ 합성예synthesis example 14] B-4의 합성 14] Synthesis of B-4

Figure 112015118508351-pat00053
Figure 112015118508351-pat00053

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-4 (3.4 g, 수율 68%)를 얻었다.It is recommended to use 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 11 was performed to obtain the target compound B-4 (3.4 g, yield 68%).

Mass (이론치: 741.88, 측정치: 741 g/mol)Mass (Theory: 741.88, Measured: 741 g/mol)

[[ 합성예synthesis example 15] B-5의 합성 15] Synthesis of B-5

Figure 112015118508351-pat00054
Figure 112015118508351-pat00054

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-5 (3.6 g, 수율 73%)를 얻었다.It is recommended to use 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 11 was performed to obtain the target compound B-5 (3.6 g, yield 73%).

Mass (이론치: 741.88, 측정치: 741 g/mol)Mass (Theory: 741.88, Measured: 741 g/mol)

[[ 합성예synthesis example 16] B-6의 합성 16] Synthesis of B-6

Figure 112015118508351-pat00055
Figure 112015118508351-pat00055

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-6 (3.9 g, 수율 71%)을 얻었다.It is recommended to use 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 11 was performed to obtain the target compound B-6 (3.9 g, yield 71%).

Mass (이론치: 816.98, 측정치: 816 g/mol)Mass (Theory: 816.98, Measured: 816 g/mol)

[[ 합성예synthesis example 17] B-7의 합성 17] Synthesis of B-7

Figure 112015118508351-pat00056
Figure 112015118508351-pat00056

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-7 (4.1 g, 수율 75%)을 얻었다.2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine , 8.0 mmol), but the same procedure as in Synthesis Example 11 was performed to obtain the target compound B-7 (4.1 g, yield 75%).

Mass (이론치: 817.97, 측정치: 817 g/mol)Mass (Theory: 817.97, Measured: 817 g/mol)

[[ 합성예synthesis example 18] B-8의 합성 18] Synthesis of B-8

Figure 112015118508351-pat00057
Figure 112015118508351-pat00057

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-8 (3.7 g, 수율 68%)을 얻었다.2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine ) The target compound B-8 (3.7 g, yield 68%) was obtained by performing the same procedure as in Synthesis Example 11 except for using.

Mass (이론치: 817.97, 측정치: 817 g/mol)Mass (Theory: 817.97, Measured: 817 g/mol)

[[ 합성예synthesis example 19] B-9의 합성 19] Synthesis of B-9

Figure 112015118508351-pat00058
Figure 112015118508351-pat00058

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-9 (3.2 g, 수율 74%)을 얻었다.The target compound was obtained by performing the same procedure as in Synthesis Example 11, except that 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Phosphorus B-9 (3.2 g, yield 74%) was obtained.

Mass (이론치: 638.75, 측정치: 638 g/mol)Mass (Theory: 638.75, Measured: 638 g/mol)

[[ 합성예synthesis example 20] B-10의 합성 20] Synthesis of B-10

Figure 112015118508351-pat00059
Figure 112015118508351-pat00059

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-10 (3.4 g, 수율 69%)을 얻었다.Purpose Compound B-10 (3.4 g, yield 69%) was obtained.

Mass (이론치: 736.9, 측정치: 736 g/mol)Mass (Theory: 736.9, Measured: 736 g/mol)

[[ 합성예synthesis example 21] C-1의 합성 21] Synthesis of C-1

Figure 112015118508351-pat00060
Figure 112015118508351-pat00060

질소 기류 하에서 준비예 3에서 합성된 EIAz-3 (2.1 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd(OAc)2 (0.08 g, 0.34 mmol), P(t-Bu)3 (0.16 ml, 0.67 mmol), NaO(t-Bu) (1.29 g, 13.4 mmol) 및 toluene (70 ml)를 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 toluenen을 농축하고, 고체염을 filter 한 뒤, 재결정으로 정제하여 목적 화합물인 C-1 (2.8 g, 수율 68%)을 얻었다.EIAz-3 (2.1 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd (OAc) 2 synthesized in Preparation Example 3 under a nitrogen stream (0.08 g, 0.34 mmol), P( t -Bu) 3 (0.16 ml, 0.67 mmol), NaO( t -Bu) (1.29 g, 13.4 mmol) and toluene (70 ml) were mixed and incubated at 110℃ for 5 hours. while stirring. After the reaction was completed, toluenen was concentrated, the solid salt was filtered, and purified by recrystallization to obtain the target compound C-1 (2.8 g, yield 68%).

Mass (이론치: 615.76, 측정치: 615 g/mol) Mass (Theory: 615.76, Measured: 615 g/mol)

[[ 합성예synthesis example 22] C-2의 합성 22] Synthesis of C-2

Figure 112015118508351-pat00061
Figure 112015118508351-pat00061

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-2 (2.3 g, 수율 64%)를 얻었다.Synthesis except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The same procedure as in Example 21 was performed to obtain the target compound C-2 (2.3 g, yield 64%).

Mass (이론치: 540.65, 측정치: 540 g/mol)Mass (Theory: 540.65, Measured: 540 g/mol)

[[ 합성예synthesis example 23] C-3의 합성 23] Synthesis of C-3

Figure 112015118508351-pat00062
Figure 112015118508351-pat00062

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-3 (3.0 g, 수율 73%)을 얻었다.Same as Synthesis Example 21 except for using 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The process was performed to obtain the target compound C-3 (3.0 g, yield 73%).

Mass (이론치: 615.76, 측정치: 615 g/mol)Mass (Theory: 615.76, Measured: 615 g/mol)

[[ 합성예synthesis example 24] C-4의 합성 24] Synthesis of C-4

Figure 112015118508351-pat00063
Figure 112015118508351-pat00063

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-4 (2.7 g, 수율 65%)를 얻었다.It is recommended to use 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 21 was performed to obtain the target compound C-4 (2.7 g, yield 65%).

Mass (이론치: 616.75, 측정치: 616 g/mol)Mass (Theory: 616.75, Measured: 616 g/mol)

[[ 합성예synthesis example 25] C-5의 합성 25] Synthesis of C-5

Figure 112015118508351-pat00064
Figure 112015118508351-pat00064

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-5 (2.9 g, 수율 70%)를 얻었다.It is recommended to use 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 21 was performed to obtain the target compound C-5 (2.9 g, yield 70%).

Mass (이론치: 616.75, 측정치: 616 g/mol)Mass (Theory: 616.75, Measured: 616 g/mol)

[[ 합성예synthesis example 26] C-6의 합성 26] Synthesis of C-6

Figure 112015118508351-pat00065
Figure 112015118508351-pat00065

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-6 (3.1 g, 수율 66%)을 얻었다.It is recommended to use 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 21 was performed to obtain the target compound C-6 (3.1 g, yield 66%).

Mass (이론치: 691.85, 측정치: 691 g/mol)Mass (Theory: 691.85, Measured: 691 g/mol)

[[ 합성예synthesis example 27] C-7의 합성 27] Synthesis of C-7

Figure 112015118508351-pat00066
Figure 112015118508351-pat00066

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-7 (3.3 g, 수율 72%)을 얻었다.2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine , 8.0 mmol) to obtain the target compound C-7 (3.3 g, yield 72%) in the same manner as in Synthesis Example 21 except for using.

Mass (이론치: 692.84, 측정치: 692 g/mol)Mass (Theory: 692.84, Measured: 692 g/mol)

[[ 합성예synthesis example 28] C-8의 합성 28] Synthesis of C-8

Figure 112015118508351-pat00067
Figure 112015118508351-pat00067

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-8 (3.5 g, 수율 75%)을 얻었다.2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine ) The same procedure as in Synthesis Example 21 was performed except for using, to obtain the target compound C-8 (3.5 g, yield 75%).

Mass (이론치: 692.84, 측정치: 692 g/mol)Mass (Theory: 692.84, Measured: 692 g/mol)

[[ 합성예synthesis example 29] C-9의 합성 29] Synthesis of C-9

Figure 112015118508351-pat00068
Figure 112015118508351-pat00068

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-9 (2.5 g, 수율 73%)을 얻었다.The target compound was obtained by performing the same procedure as in Synthesis Example 21, except that 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Phosphorus C-9 (2.5 g, yield 73%) was obtained.

Mass (이론치: 513.62, 측정치: 513 g/mol)Mass (Theory: 513.62, Measured: 513 g/mol)

[[ 합성예synthesis example 30] C-10의 합성 30] Synthesis of C-10

Figure 112015118508351-pat00069
Figure 112015118508351-pat00069

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-10 (2.8 g, 수율 68%)을 얻었다.Purpose Compound C-10 (2.8 g, yield 68%) was obtained.

Mass (이론치: 611.8, 측정치: 611 g/mol)Mass (Theory: 611.8, Measured: 611 g/mol)

[[ 합성예synthesis example 31] D-1의 합성 31] Synthesis of D-1

Figure 112015118508351-pat00070
Figure 112015118508351-pat00070

질소 기류 하에서 준비예 4에서 합성된 EIAz-4 (2.4 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd(OAc)2 (0.08 g, 0.34 mmol), P(t-Bu)3 (0.16 ml, 0.67 mmol), NaO(t-Bu) (1.29 g, 13.4 mmol) 및 toluene (70 ml)를 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 toluenen을 농축하고, 고체염을 filter 한 뒤, 재결정으로 정제하여 목적 화합물인 D-1 (3.2 g, 수율 72%)을 얻었다.EIAz-4 (2.4 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd (OAc) 2 synthesized in Preparation Example 4 under a nitrogen stream (0.08 g, 0.34 mmol), P( t -Bu) 3 (0.16 ml, 0.67 mmol), NaO( t -Bu) (1.29 g, 13.4 mmol) and toluene (70 ml) were mixed and incubated at 110℃ for 5 hours. while stirring. After the reaction was completed, toluenen was concentrated, the solid salt was filtered, and purified by recrystallization to obtain the target compound D-1 (3.2 g, yield 72%).

Mass (이론치: 665.82, 측정치: 665 g/mol) Mass (Theory: 665.82, Measured: 665 g/mol)

[[ 합성예synthesis example 32] D-2의 합성 32] Synthesis of D-2

Figure 112015118508351-pat00071
Figure 112015118508351-pat00071

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-2 (3.0 g, 수율 75%)를 얻었다.Synthesis except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The same procedure as in Example 31 was performed to obtain the target compound D-2 (3.0 g, yield 75%).

Mass (이론치: 590.71, 측정치: 590 g/mol)Mass (Theory: 590.71, Measured: 590 g/mol)

[[ 합성예synthesis example 33] D-3의 합성 33] Synthesis of D-3

Figure 112015118508351-pat00072
Figure 112015118508351-pat00072

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-3 (3.1 g, 수율 70%)을 얻었다.Same as Synthesis Example 31 except for using 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The process was performed to obtain the target compound D-3 (3.1 g, yield 70%).

Mass (이론치: 665.82, 측정치: 665 g/mol)Mass (Theory: 665.82, Measured: 665 g/mol)

[[ 합성예synthesis example 34] D-4의 합성 34] Synthesis of D-4

Figure 112015118508351-pat00073
Figure 112015118508351-pat00073

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-4 (3.0 g, 수율 68%)를 얻었다.It is recommended to use 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 31 was performed to obtain the target compound D-4 (3.0 g, yield 68%).

Mass (이론치: 666.81, 측정치: 666 g/mol)Mass (Theory: 666.81, Measured: 666 g/mol)

[[ 합성예synthesis example 35] D-5의 합성 35] Synthesis of D-5

Figure 112015118508351-pat00074
Figure 112015118508351-pat00074

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-5 (3.3 g, 수율 74%)를 얻었다.It is recommended to use 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 31 was performed to obtain the target compound D-5 (3.3 g, yield 74%).

Mass (이론치: 666.81, 측정치: 666 g/mol)Mass (Theory: 666.81, Measured: 666 g/mol)

[[ 합성예synthesis example 36] D-6의 합성 36] Synthesis of D-6

Figure 112015118508351-pat00075
Figure 112015118508351-pat00075

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-6 (3.6 g, 수율 72%)을 얻었다.It is recommended to use 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 31 was performed to obtain the target compound D-6 (3.6 g, yield 72%).

Mass (이론치: 741.91, 측정치: 741 g/mol)Mass (Theory: 741.91, Measured: 741 g/mol)

[[ 합성예synthesis example 37] D-7의 합성 37] Synthesis of D-7

Figure 112015118508351-pat00076
Figure 112015118508351-pat00076

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-7 (3.5 g, 수율 70%)을 얻었다.2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine , 8.0 mmol) was performed in the same manner as in Synthesis Example 31 to obtain the target compound D-7 (3.5 g, yield 70%).

Mass (이론치: 742.90, 측정치: 742 g/mol)Mass (Theory: 742.90, Measured: 742 g/mol)

[[ 합성예synthesis example 38] D-8의 합성 38] Synthesis of D-8

Figure 112015118508351-pat00077
Figure 112015118508351-pat00077

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-8 (3.4 g, 수율 69%)을 얻었다.2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine ) The target compound D-8 (3.4 g, yield 69%) was obtained by performing the same procedure as in Synthesis Example 31 except for using.

Mass (이론치: 742.90, 측정치: 742 g/mol)Mass (Theory: 742.90, Measured: 742 g/mol)

[[ 합성예synthesis example 39] D-9의 합성 39] Synthesis of D-9

Figure 112015118508351-pat00078
Figure 112015118508351-pat00078

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-9 (2.8 g, 수율 75%)을 얻었다.The target compound was obtained by performing the same procedure as in Synthesis Example 31, except that 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Phosphorus D-9 (2.8 g, yield 75%) was obtained.

Mass (이론치: 563.68, 측정치: 563 g/mol)Mass (Theory: 563.68, Measured: 563 g/mol)

[[ 합성예synthesis example 40] D-10의 합성 40] Synthesis of D-10

Figure 112015118508351-pat00079
Figure 112015118508351-pat00079

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-10 (3.2 g, 수율 72%)을 얻었다.Purpose Compound D-10 (3.2 g, yield 72%) was obtained.

Mass (이론치: 661.83, 측정치: 661 g/mol)Mass (Theory: 661.83, Measured: 661 g/mol)

[[ 합성예synthesis example 41] E-1의 합성 41] Synthesis of E-1

Figure 112015118508351-pat00080
Figure 112015118508351-pat00080

질소 기류 하에서 준비예 5에서 합성된 EIAz-5 (3.4 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 E-1 (3.2 g, 수율 68%)을 얻었다.EIAz-5 (3.4 g, 6.7 mmol), 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine (2.74 g, 8.0 mmol), Pd (PPh 3 ) synthesized in Preparation Example 5 under a nitrogen stream 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110° C. for 5 hours. After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound E-1 (3.2 g, yield 68%).

Mass (이론치: 691.86, 측정치: 691 g/mol) Mass (Theory: 691.86, Measured: 691 g/mol)

[[ 합성예synthesis example 42] E-2의 합성 42] Synthesis of E-2

Figure 112015118508351-pat00081
Figure 112015118508351-pat00081

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-2 (3.1 g, 수율 75%)를 얻었다.Synthesis except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The same procedure as in Example 41 was performed to obtain the target compound E-2 (3.1 g, yield 75%).

Mass (이론치: 616.75, 측정치: 616 g/mol)Mass (Theory: 616.75, Measured: 616 g/mol)

[[ 합성예synthesis example 43] E-3의 합성 43] Synthesis of E-3

Figure 112015118508351-pat00082
Figure 112015118508351-pat00082

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-3 (3.2 g, 수율 69%)을 얻었다.Same as Synthesis Example 41 except for using 4-(4-bromophenyl)-2,6-diphenylpyrimidine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. The process was performed to obtain the target compound E-3 (3.2 g, yield 69%).

Mass (이론치: 691.86, 측정치: 691 g/mol)Mass (Theory: 691.86, Measured: 691 g/mol)

[[ 합성예synthesis example 44] E-4의 합성 44] Synthesis of E-4

Figure 112015118508351-pat00083
Figure 112015118508351-pat00083

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-4 (3.4 g, 수율 73%)를 얻었다.It is recommended to use 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 41 was performed to obtain the target compound E-4 (3.4 g, yield 73%).

Mass (이론치: 692.85, 측정치: 692 g/mol)Mass (Theory: 692.85, Measured: 692 g/mol)

[[ 합성예synthesis example 45] E-5의 합성 45] Synthesis of E-5

Figure 112015118508351-pat00084
Figure 112015118508351-pat00084

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-5 (3.2 g, 수율 70%)를 얻었다.It is recommended to use 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 41 was performed to obtain the target compound E-5 (3.2 g, yield 70%).

Mass (이론치: 692.85, 측정치: 692 g/mol)Mass (Theory: 692.85, Measured: 692 g/mol)

[[ 합성예synthesis example 46] E-6의 합성 46] Synthesis of E-6

Figure 112015118508351-pat00085
Figure 112015118508351-pat00085

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-6 (3.3 g, 수율 65%)을 얻었다.It is recommended to use 4-(biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Except for the same procedure as in Synthesis Example 41 was performed to obtain the target compound E-6 (3.3 g, yield 65%).

Mass (이론치: 767.95, 측정치: 767 g/mol)Mass (Theory: 767.95, Measured: 767 g/mol)

[[ 합성예synthesis example 47] E-7의 합성 47] Synthesis of E-7

Figure 112015118508351-pat00086
Figure 112015118508351-pat00086

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-7 (3.6 g, 수율 70%)을 얻었다.2-(biphenyl-4-yl)-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine (3.4 g) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine , 8.0 mmol) to obtain the target compound E-7 (3.6 g, yield 70%) in the same manner as in Synthesis Example 41 except for using.

Mass (이론치: 768.94, 측정치: 768 g/mol)Mass (Theory: 768.94, Measured: 768 g/mol)

[[ 합성예synthesis example 48] E-8의 합성 48] Synthesis of E-8

Figure 112015118508351-pat00087
Figure 112015118508351-pat00087

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-8 (3.8 g, 수율 74%)을 얻었다.2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (3.7 g, 8.0 mmol) instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine ) The target compound E-8 (3.8 g, yield 74%) was obtained by performing the same procedure as in Synthesis Example 41 except for using.

Mass (이론치: 768.94, 측정치: 768 g/mol)Mass (Theory: 768.94, Measured: 768 g/mol)

[[ 합성예synthesis example 49] E-9의 합성 49] Synthesis of E-9

Figure 112015118508351-pat00088
Figure 112015118508351-pat00088

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-9 (2.7 g, 수율 68%)을 얻었다.The target compound was obtained by performing the same procedure as in Synthesis Example 41, except that 2-chloro-4-phenylquinazoline (2.9 g, 8.0 mmol) was used instead of 4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine. Phosphorus E-9 (2.7 g, yield 68%) was obtained.

Mass (이론치: 589.72, 측정치: 589 g/mol)Mass (Theory: 589.72, Measured: 589 g/mol)

[[ 합성예synthesis example 50] E-10의 합성 50] Synthesis of E-10

Figure 112015118508351-pat00089
Figure 112015118508351-pat00089

4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine 대신 2-(3-bromophenyl)triphenylene (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-10 (3.3 g, 수율 72%)을 얻었다.Purpose Compound E-10 (3.3 g, yield 72%) was obtained.

Mass (이론치: 687.87, 측정치: 687 g/mol)Mass (Theory: 687.87, Measured: 687 g/mol)

[[ 합성예synthesis example 51] F-1의 합성 51] Synthesis of F-1

Figure 112015118508351-pat00090
Figure 112015118508351-pat00090

질소 기류 하에서 준비예 1에서 합성된 EIAz-1 (3.8 g, 6.7 mmol), N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 F-1 (3.9 g, 수율 65%)을 얻었다.EIAz-1 (3.8 g, 6.7 mmol), N,N-di (biphenyl-4-yl) -4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd synthesized in Preparation Example 1 under a nitrogen stream (PPh 3 ) 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110°C for 5 hours. did After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound, F-1 (3.9 g, yield 65%).

Mass (이론치: 906.12, 측정치: 906 g/mol) Mass (Theory: 906.12, Measured: 906 g/mol)

[[ 합성예synthesis example 52] F- 52] F- 2 의2 of 합성 synthesis

Figure 112015118508351-pat00091
Figure 112015118508351-pat00091

N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine 대신 N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-2 (3.6 g, 수율 66%)를 얻었다.Instead of N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine, N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol) was used. Except for the use, the same procedure as in Synthesis Example 51 was performed to obtain the target compound F-2 (3.6 g, yield 66%).

Mass (이론치: 803.99, 측정치: 804 g/mol)Mass (Theory: 803.99, Measured: 804 g/mol)

[[ 합성예synthesis example 53] F- 53] F- 3 의3 of 합성 synthesis

Figure 112015118508351-pat00092
Figure 112015118508351-pat00092

질소 기류 하에서 준비예 2에서 합성된 EIAz-2 (3.8 g, 6.7 mmol), N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 F-3 (4.2 g, 수율 70%)을 얻었다.EIAz-2 (3.8 g, 6.7 mmol), N,N-di (biphenyl-4-yl) -4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd synthesized in Preparation Example 2 under nitrogen stream (PPh 3 ) 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110°C for 5 hours. did After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound, F-3 (4.2 g, yield 70%).

Mass (이론치: 906.12, 측정치: 906 g/mol) Mass (Theory: 906.12, Measured: 906 g/mol)

[[ 합성예synthesis example 54] F- 54] F- 4 의4 of 합성 synthesis

Figure 112015118508351-pat00093
Figure 112015118508351-pat00093

N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine 대신 N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 53과 동일한 과정을 수행하여 목적 화합물인 F-4 (3.4 g, 수율 63%)를 얻었다.N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine instead of N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine N-(4'-bromobiphenyl- Except for using 4-yl) -N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol), the same procedure as in Synthesis Example 53 was performed to obtain the target compound F-4 (3.4 g, yield 63%). got it

Mass (이론치: 803.99, 측정치: 804 g/mol)Mass (Theory: 803.99, Measured: 804 g/mol)

[[ 합성예synthesis example 55] F-5의 합성 55] Synthesis of F-5

Figure 112015118508351-pat00094
Figure 112015118508351-pat00094

질소 기류 하에서 준비예 3에서 합성된 EIAz-3 (2.1 g, 6.7 mmol), N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd(OAc)2 (0.08 g, 0.34 mmol), P(t-Bu)3 (0.16 ml, 0.67 mmol), NaO(t-Bu) (1.29 g, 13.4 mmol) 및 toluene (70 ml)를 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 toluenen을 농축하고, 고체염을 filter 한 뒤, 재결정으로 정제하여 목적 화합물인 F-5 (3.5 g, 수율 66%)을 얻었다.EIAz-3 (2.1 g, 6.7 mmol), N,N-di (biphenyl-4-yl) -4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd synthesized in Preparation Example 3 under a nitrogen stream (OAc) 2 (0.08 g, 0.34 mmol), P( t -Bu) 3 (0.16 ml, 0.67 mmol), NaO( t -Bu) (1.29 g, 13.4 mmol) and toluene (70 ml) were mixed and heated to 110 It was stirred for 5 hours at °C. After the reaction was completed, toluenen was concentrated, the solid salt was filtered, and purified by recrystallization to obtain the target compound F-5 (3.5 g, yield 66%).

Mass (이론치: 780.99, 측정치: 780 g/mol) Mass (Theory: 780.99, Measured: 780 g/mol)

[[ 합성예synthesis example 56] F-6의 합성 56] Synthesis of F-6

Figure 112015118508351-pat00095
Figure 112015118508351-pat00095

N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine 대신 N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 과정을 수행하여 목적 화합물인 F-6 (3.0 g, 수율 65%)를 얻었다.Instead of N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine, N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol) was used. Except for the use, the same procedure as in Synthesis Example 55 was performed to obtain the target compound F-6 (3.0 g, yield 65%).

Mass (이론치: 678.86, 측정치: 678 g/mol)Mass (Theory: 678.86, Measured: 678 g/mol)

[[ 합성예synthesis example 57] F-7의 합성 57] Synthesis of F-7

Figure 112015118508351-pat00096
Figure 112015118508351-pat00096

질소 기류 하에서 준비예 4에서 합성된 EIAz-4 (2.4 g, 6.7 mmol), N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd(OAc)2 (0.08 g, 0.34 mmol), P(t-Bu)3 (0.16 ml, 0.67 mmol), NaO(t-Bu) (1.29 g, 13.4 mmol) 및 toluene (70 ml)를 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 toluenen을 농축하고, 고체염을 filter 한 뒤, 재결정으로 정제하여 목적 화합물인 F-7 (3.3 g, 수율 60%)을 얻었다.EIAz-4 (2.4 g, 6.7 mmol), N,N-di (biphenyl-4-yl) -4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd synthesized in Preparation Example 4 under nitrogen stream (OAc) 2 (0.08 g, 0.34 mmol), P( t -Bu) 3 (0.16 ml, 0.67 mmol), NaO( t -Bu) (1.29 g, 13.4 mmol) and toluene (70 ml) were mixed and heated to 110 It was stirred for 5 hours at °C. After the reaction was completed, toluenen was concentrated, the solid salt was filtered, and purified by recrystallization to obtain the target compound, F-7 (3.3 g, yield 60%).

Mass (이론치: 831.05, 측정치: 831 g/mol) Mass (Theory: 831.05, Measured: 831 g/mol)

[[ 합성예synthesis example 58] F-8의 합성 58] Synthesis of F-8

Figure 112015118508351-pat00097
Figure 112015118508351-pat00097

N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine 대신 N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 57과 동일한 과정을 수행하여 목적 화합물인 F-8 (3.5 g, 수율 71%)를 얻었다.Instead of N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine, N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol) was used. Except for the use, the same procedure as in Synthesis Example 57 was performed to obtain the target compound F-8 (3.5 g, yield 71%).

Mass (이론치: 728.92, 측정치: 728 g/mol)Mass (Theory: 728.92, Measured: 728 g/mol)

[[ 합성예synthesis example 59] F-9의 합성 59] Synthesis of F-9

Figure 112015118508351-pat00098
Figure 112015118508351-pat00098

질소 기류 하에서 준비예 5에서 합성된 EIAz-5 (3.4 g, 6.7 mmol), N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd(PPh3)4 (0.39 g, 0.34 mmol), K2CO3 (2.32g, 16.75 mmol), toluene/EtOH/H20 (50/30/20 ml)을 혼합하고 110℃ 에서 5시간 동안 교반하였다. 반응이 종결된 후 MC로 추출한 다음 MgSO4로 수분을 제거하고, 재결정으로 정제하여 목적 화합물인 F-9 (3.8 g, 수율 67%)을 얻었다.EIAz-5 (3.4 g, 6.7 mmol), N,N-di (biphenyl-4-yl) -4'-chlorobiphenyl-4-amine (4.1 g, 8.0 mmol), Pd synthesized in Preparation Example 5 under a nitrogen stream (PPh 3 ) 4 (0.39 g, 0.34 mmol), K 2 CO 3 (2.32 g, 16.75 mmol), and toluene/EtOH/H 2 0 (50/30/20 ml) were mixed and stirred at 110°C for 5 hours. did After the reaction was completed, extraction was performed with MC, water was removed with MgSO 4 , and purification was performed by recrystallization to obtain the target compound, F-9 (3.8 g, yield 67%).

Mass (이론치: 857.09, 측정치: 857 g/mol) Mass (Theory: 857.09, Measured: 857 g/mol)

[[ 합성예synthesis example 60] F-10의 합성 60] Synthesis of F-10

Figure 112015118508351-pat00099
Figure 112015118508351-pat00099

N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine 대신 N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 59과 동일한 과정을 수행하여 목적 화합물인 F-10 (3.2 g, 수율 64%)를 얻었다.Instead of N,N-di(biphenyl-4-yl)-4'-chlorobiphenyl-4-amine, N-(4'-bromobiphenyl-4-yl)-N-phenylnaphthalen-1-amine (3.6 g, 8.0 mmol) was used. Except for the use, the same procedure as in Synthesis Example 59 was performed to obtain the target compound F-10 (3.2 g, yield 64%).

Mass (이론치: 754.96, 측정치: 754 g/mol)Mass (Theory: 754.96, Measured: 754 g/mol)

[[ 실시예Example 1 내지 45] 녹색 유기 1 to 45] green organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

합성예에서 합성된 화합물 A-1 내지 A-8, A-10, B-1 내지 B-8, B-10, C-1 내지 C-8, C-10, D-1 내지 D-8, D-10, E-1 내지 E-8, E-10을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 전계 발광 소자를 제조하였다.Compounds A-1 to A-8, A-10, B-1 to B-8, B-10, C-1 to C-8, C-10, D-1 to D-8 synthesized in Synthesis Examples; D-10, E-1 to E-8, and E-10 were sublimated to high purity by a commonly known method, and then a green organic electroluminescent device was prepared according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water and ultrasonic waves. After washing with distilled water, it is ultrasonically washed with solvents such as isopropyl alcohol, acetone, and methanol, dried, transferred to a UV OZONE cleaner (Power Sonic 405, Hwashin Tech), and then cleaned by using UV for 5 minutes and vacuum evaporator The substrate was transferred to

상기와 같이 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ 90%의 각각의 화합물 A-1 내지 A-8, A-10, B-1 내지 B-8, B-10, C-1 내지 C-8, C-10, D-1 내지 D-8, D-10, E-1 내지 E-8, E-10 + 10%의 Ir(ppy)3 (300 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다. m-MTDATA (60 nm) / TCTA (80 nm) / 90% of each compound A-1 to A-8, A-10, B-1 to B-8, B- on the ITO transparent electrode prepared as above 10, C-1 to C-8, C-10, D-1 to D-8, D-10, E-1 to E-8, E-10 + 10% of Ir(ppy) 3 (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) were laminated in this order to prepare an organic light emitting device.

[[ 비교예comparative example 1] 녹색 유기 1] Green organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

발광층 형성시 발광 호스트 물질로서 화합물 A-1 대신 CBP를 사용하는 것을 제외하고는, 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.A green organic electroluminescent device was fabricated in the same manner as in Example 1, except that CBP was used instead of Compound A-1 as the light emitting host material when forming the light emitting layer.

상기 실시예 1 내지 45 및 비교예 1에서 사용된 m-MTDATA, TCTA, Ir(ppy)3, CBP, Alq3 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir(ppy) 3 , CBP, Alq 3 and BCP used in Examples 1 to 45 and Comparative Example 1 are as follows.

Figure 112015118508351-pat00100
Figure 112015118508351-pat00100

Figure 112015118508351-pat00101
Figure 112015118508351-pat00101

[[ 평가예evaluation example 1] One]

실시예 1 내지 45 및 비교예 1에서 각각 제조한 녹색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1 및 2에 나타내었다.Driving voltage, current efficiency and emission peak at a current density of 10 mA/cm 2 were measured for the green organic electroluminescent devices prepared in Examples 1 to 45 and Comparative Example 1, respectively, and the results are shown in Tables 1 and 2 below. was

샘플Sample 호스트host 구동전압 (V)Driving voltage (V) 발광 피크 (nm)Emission peak (nm) 전류효율 (cd/A)Current efficiency (cd/A) 실시예 1Example 1 A-1A-1 6.866.86 518518 38.938.9 실시예 2Example 2 A-2A-2 6.486.48 518518 41.341.3 실시예 3Example 3 A-3A-3 6.486.48 517517 41.341.3 실시예 4Example 4 A-4A-4 6.866.86 515515 41.341.3 실시예 5Example 5 A-5A-5 6.776.77 518518 41.241.2 실시예 6Example 6 A-6A-6 6.666.66 518518 38.938.9 실시예 7Example 7 A-7A-7 6.656.65 517517 41.341.3 실시예 8Example 8 A-8A-8 6.776.77 515515 41.241.2 실시예 9Example 9 A-10A-10 6.776.77 518518 38.938.9 실시예 10Example 10 B-1B-1 6.666.66 518518 41.341.3 실시예 11Example 11 B-2B-2 6.656.65 517517 41.341.3 실시예 12Example 12 B-3B-3 6.776.77 515515 41.341.3 실시예 13Example 13 B-4B-4 6.666.66 518518 41.241.2 실시예 14Example 14 B-5B-5 6.666.66 518518 38.938.9 실시예 15Example 15 B-6B-6 6.816.81 517517 41.341.3 실시예 16Example 16 B-7B-7 6.686.68 515515 41.341.3 실시예 17Example 17 B-8B-8 6.666.66 518518 41.341.3 실시예 18Example 18 B-10B-10 6.706.70 518518 41.241.2 실시예 19Example 19 C-1C-1 6.666.66 517517 42.242.2 실시예 20Example 20 C-2C-2 6.666.66 515515 42.042.0 실시예 21Example 21 C-3C-3 6.816.81 518518 39.739.7 실시예 22Example 22 C-4C-4 6.686.68 518518 38.938.9 실시예 23Example 23 C-5C-5 6.666.66 518518 41.341.3 실시예 24Example 24 C-6C-6 6.706.70 517517 41.341.3 실시예 25Example 25 C-7C-7 6.706.70 515515 43.143.1 실시예 26Example 26 C-8C-8 6.516.51 518518 43.543.5 실시예 27Example 27 C-10C-10 6.776.77 518518 41.441.4 실시예 28Example 28 D-1D-1 6.706.70 517517 43.143.1 실시예 29Example 29 D-2D-2 6.516.51 515515 41.341.3 실시예 30Example 30 D-3D-3 6.776.77 515515 41.341.3 실시예 31Example 31 D-4D-4 6.466.46 515515 41.341.3 실시예 32Example 32 D-5D-5 6.516.51 515515 41.241.2 실시예 33Example 33 D-6D-6 6.776.77 518518 38.938.9 실시예 34Example 34 D-7D-7 6.706.70 518518 41.341.3 실시예 35Example 35 D-8D-8 6.516.51 517517 41.341.3 실시예 36Example 36 D-10D-10 6.776.77 515515 41.341.3

샘플Sample 호스트host 구동전압 (V)Driving voltage (V) 발광 피크 (nm)Emission peak (nm) 전류효율 (cd/A)Current efficiency (cd/A) 실시예 37Example 37 E-1E-1 6.866.86 518518 41.241.2 실시예 38Example 38 E-2E-2 6.776.77 517517 42.042.0 실시예 39Example 39 E-3E-3 6.666.66 518518 39.739.7 실시예 40Example 40 E-4E-4 6.666.66 517517 38.938.9 실시예 41Example 41 E-5E-5 6.776.77 518518 41.341.3 실시예 42Example 42 E-6E-6 6.706.70 518518 41.341.3 실시예 43Example 43 E-7E-7 6.516.51 518518 43.143.1 실시예 44Example 44 E-8E-8 6.776.77 517517 41.341.3 실시예 45Example 45 E-10E-10 6.776.77 518518 38.938.9 비교예 1Comparative Example 1 CBPCBP 6.936.93 516516 38.238.2

상기 표 1 및 2에 나타낸 바와 같이, 본 발명에 따른 화합물을 발광층에 사용한 녹색 유기 전계 발광 소자(실시예 1 내지 45)는 종래 CBP를 발광층에 사용한 녹색 유기 전계 발광 소자(비교예1)에 비해 전류효율 및 구동전압이 우수한 것을 확인할 수 있었다.As shown in Tables 1 and 2, the green organic electroluminescent device (Examples 1 to 45) using the compound according to the present invention in the light emitting layer is compared to the green organic electroluminescent device (Comparative Example 1) using the conventional CBP in the light emitting layer. It was confirmed that the current efficiency and driving voltage were excellent.

[[ 실시예Example 46 내지 50] 적색 유기 46 to 50] red organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

합성예에서 합성된 화합물 A-9, B-9, C-9, D-9, E-9을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 적색 유기 전계 발광 소자를 제조하였다.Compounds A-9, B-9, C-9, D-9, and E-9 synthesized in Synthesis Example were subjected to high-purity sublimation purification by a conventionally known method, and then a red organic electroluminescent device was prepared according to the following procedure. .

먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water and ultrasonic waves. After washing with distilled water, it is ultrasonically washed with solvents such as isopropyl alcohol, acetone, and methanol, dried, transferred to a UV OZONE cleaner (Power Sonic 405, Hwashin Tech), and then cleaned by using UV for 5 minutes and vacuum evaporator The substrate was transferred to

상기와 같이 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm) / 90%의 화합물 A-9, B-9, C-9, D-9, E-9 + 10%의 (piq)2Ir(acac) (300 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.m-MTDATA (60 nm) / TCTA (80 nm) / 90% of compounds A-9, B-9, C-9, D-9, E-9 + 10% of ( piq) 2 Ir(acac) (300 nm)/BCP (10 nm)/Alq 3 (30 nm)/LiF (1 nm)/Al (200 nm) were stacked in this order to prepare an organic electroluminescent device.

[[ 비교예comparative example 2] 2]

발광층 형성시 발광 호스트 물질로서 화합물 A-9 대신 CBP를 사용하는 것을 제외하고는, 상기 실시예 46과 동일한 과정으로 적색 유기 전계 발광 소자를 제조하였다.A red organic electroluminescent device was manufactured in the same manner as in Example 46, except that CBP was used instead of Compound A-9 as the light emitting host material when forming the light emitting layer.

상기 실시예 46 내지 50 및 비교예 2에서 사용된 (piq)2Ir(acac)의 구조는 하기와 같다.The structure of (piq) 2 Ir(acac) used in Examples 46 to 50 and Comparative Example 2 is as follows.

Figure 112015118508351-pat00102
Figure 112015118508351-pat00102

[[ 평가예evaluation example 2] 2]

실시예 46 내지 50 및 비교예 2에서 각각 제조한 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 3에 나타내었다.For the organic electroluminescent devices prepared in Examples 46 to 50 and Comparative Example 2, driving voltage and current efficiency at a current density of 10 mA/cm 2 were measured, and the results are shown in Table 3 below.

샘플Sample 호스트host 구동전압 (V)Driving voltage (V) 전류효율 (cd/A)Current efficiency (cd/A) 실시예 46Example 46 A-9A-9 4.944.94 12.512.5 실시예 47Example 47 B-9B-9 4.814.81 10.810.8 실시예 48Example 48 C-9C-9 4.644.64 13.213.2 실시예 49Example 49 D-9D-9 4.874.87 11.911.9 실시예 50Example 50 E-9E-9 4.784.78 13.113.1 비교예 2Comparative Example 2 CBPCBP 5.255.25 8.28.2

상기 표 3에 나타낸 바와 같이, 본 발명에 따른 화합물을 발광층에 사용한 적색 유기 전계 발광 소자(실시예 46 내지 50)는 종래 CBP를 발광층에 사용한 적색 유기 전계 발광 소자(비교예2)에 비해 전류효율 및 구동전압이 우수한 것을 확인할 수 있었다.As shown in Table 3, the red organic electroluminescent device (Examples 46 to 50) using the compound according to the present invention in the light emitting layer has current efficiency compared to the red organic light emitting device (Comparative Example 2) using the conventional CBP in the light emitting layer. And it was confirmed that the driving voltage was excellent.

[[ 실시예Example 51 내지 60] 유기 51 to 60] organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

합성예에서 합성된 화합물 F-1 내지 F-10을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 유기 전계 발광 소자를 제조하였다.Compounds F-1 to F-10 synthesized in Synthesis Example were subjected to high-purity sublimation purification by a conventionally known method, and an organic electroluminescent device was prepared according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5 분간 세정한 후 진공 층착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water and ultrasonic waves. After washing with distilled water, it is ultrasonically washed with solvents such as isopropyl alcohol, acetone, and methanol, dried, transferred to a UV OZONE cleaner (Power Sonic 405, Hwashin Tech), and then cleaned by using UV for 5 minutes. Afterwards, the substrate was transferred to a vacuum layering machine.

상기와 같이 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/ 각각의 화합물 F-1 내지 F-10 (80 nm)/DS-H522 + 5%의 DS-501(㈜두산전자, 30 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다. m-MTDATA (60 nm)/ each compound F-1 to F-10 (80 nm)/ DS-H522 + 5% of DS-501 (Doosan Electronics Co., Ltd., 30 nm)/ BCP (10 nm)/Alq 3 (30 nm)/LiF (1 nm)/Al (200 nm) were laminated in this order to prepare an organic light emitting device.

[[ 비교예comparative example 3] 유기 3] organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

정공 수송층 형성시 정공 수송층 물질로 화합물 F-1 대신 NPB를 사용한 것을 제외하고는, 실시예 51과 동일한 과정으로 유기 전계 발광 소자를 제조하였다. An organic electroluminescent device was manufactured in the same manner as in Example 51, except that NPB was used instead of Compound F-1 as the hole transport layer material when forming the hole transport layer.

상기 비교예 3에서 사용된 NPB의 구조는 하기와 같다.The structure of the NPB used in Comparative Example 3 is as follows.

Figure 112015118508351-pat00103
Figure 112015118508351-pat00103

[[ 평가예evaluation example 3] 3]

실시예 51 내지 60 및 비교예 3에서 각각 제조된 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율를 측정하였고, 그 결과를 하기 표 4에 나타내었다.The driving voltage and current efficiency at a current density of 10 mA/cm 2 were measured for the organic electroluminescent devices prepared in Examples 51 to 60 and Comparative Example 3, respectively, and the results are shown in Table 4 below.

샘플Sample 정공 수송층hole transport layer 구동전압 (V)Driving voltage (V) 전류효율 (cd/A)Current efficiency (cd/A) 실시예 51Example 51 F-1F-1 4.94.9 21.121.1 실시예 52Example 52 F-2F-2 4.64.6 19.419.4 실시예 53Example 53 F-3F-3 4.84.8 20.020.0 실시예 54Example 54 F-4F-4 4.34.3 19.319.3 실시예 55Example 55 F-5F-5 4.84.8 19.219.2 실시예 56Example 56 F-6F-6 4.64.6 21.121.1 실시예 57Example 57 F-7F-7 4.84.8 19.419.4 실시예 58Example 58 F-8F-8 4.34.3 20.020.0 실시예 59Example 59 F-9F-9 4.64.6 19.319.3 실시예 60Example 60 F-10F-10 4.84.8 19.219.2 비교예 3Comparative Example 3 NPBNPB 5.25.2 18.118.1

상기 표 4에 나타낸 바와 같이, 본 발명에 따른 화합물을 정공 수송층으로 사용한 유기 전계 발광 소자(실시예 51 내지 60)는 종래 NPB를 정공 수송층으로 사용한 유기 전계 발광 소자(비교예3)에 비해 전류효율 및 구동전압이 우수한 것을 확인할 수 있었다.As shown in Table 4, the organic electroluminescent device (Examples 51 to 60) using the compound according to the present invention as a hole transport layer has higher current efficiency than the organic electroluminescent device (Comparative Example 3) using a conventional NPB as a hole transport layer. And it was confirmed that the driving voltage was excellent.

[[ 실시예Example 61 내지 100] 청색 유기 61 to 100] blue organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

합성예에서 합성된 화합물 A-1 내지 A-8, B-1 내지 B-8, C-1 내지 C-8, D-1 내지 D-8, E-1 내지 E-8을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 청색 유기 전계 발광 소자를 제조하였다.Compounds A-1 to A-8, B-1 to B-8, C-1 to C-8, D-1 to D-8, and E-1 to E-8 synthesized in Synthesis Example were prepared by commonly known methods. After sublimation purification with high purity, a blue organic electroluminescent device was prepared as follows.

먼저, ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고, 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water and ultrasonic waves. After the distilled water cleaning is finished, ultrasonic cleaning is performed with solvents such as isopropyl alcohol, acetone, and methanol, and after drying, the substrate is transferred to a UV OZONE cleaner (Power Sonic 405, Hwashin Tech), and then the substrate is cleaned using UV for 5 minutes. After cleaning, the substrate was transferred to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (㈜두산전자, 80 nm)/NPB (15 nm)/AND + 5%의 DS-405(㈜두산전자) (30 nm)/각각의 화합물 A-1 내지 A-8, B-1 내지 B-8, C-1 내지 C-8, D-1 내지 D-8, E-1 내지 E-8 (5 nm)/ Alq3 (25 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.On the ITO transparent electrode prepared as above, DS-205 (Doosan Electronics, 80 nm)/NPB (15 nm)/AND + 5% DS-405 (Doosan Electronics) (30 nm)/each compound A- 1 to A-8, B-1 to B-8, C-1 to C-8, D-1 to D-8, E-1 to E-8 (5 nm) / Alq 3 (25 nm) / LiF (1 nm)/Al (200 nm) were laminated in this order to prepare an organic electroluminescent device.

[[ 비교예comparative example 4] 청색 유기 4] Blue organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

수명 개선층을 포함하지 않고, 전자 수송층 물질인 Alq3을 25 nm 대신 30 nm로 증착하는 것을 제외하고는, 실시예 61과 동일한 과정으로 청색 유기 전계 발광 소자를 제조하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 61, except that the lifespan improvement layer was not included and Alq 3 , an electron transport layer material, was deposited in a thickness of 30 nm instead of 25 nm.

[[ 비교예comparative example 5] 청색 유기 5] Blue organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

수명 개선층 형성시 수명 개선층 물질로서 화합물 A-1 대신 BCP를 사용하는 것을 제외하고는, 실시예 61과 동일한 과정으로 청색 유기 전계 발광 소자를 제조하였다. A blue organic electroluminescent device was manufactured in the same manner as in Example 61, except for using BCP instead of Compound A-1 as a material for the lifespan improvement layer when forming the lifespan improvement layer.

상기 실시예 61 내지 100 및 비교예 4, 5에서 사용된 AND의 구조는 하기와 같다.The structure of AND used in Examples 61 to 100 and Comparative Examples 4 and 5 is as follows.

Figure 112015118508351-pat00104
Figure 112015118508351-pat00104

[[ 평가예evaluation example 4] 4]

실시예 61 내지 100 및 비교예 4, 5에서 각각 제조된 유기 전계 발광 소자에 대하여, 전류밀도 10 mA/㎠에서의 구동전압, 전류효율, 발광파장 및 수명(T97)을 측정하였고, 그 결과를 하기 표 5 및 6에 나타내었다.For the organic electroluminescent devices prepared in Examples 61 to 100 and Comparative Examples 4 and 5, respectively, the driving voltage, current efficiency, emission wavelength and lifetime (T 97 ) at a current density of 10 mA/cm 2 were measured, and the results are shown in Tables 5 and 6 below.

샘플Sample 수명 개선층life improvement layer 구동전압 (V)Driving voltage (V) 전류효율 (cd/A)Current efficiency (cd/A) 발광 피크 (nm)Emission peak (nm) 수명 (hr, T97)Life (hr, T 97 ) 실시예 61Example 61 A-1A-1 4.34.3 6.26.2 459459 3838 실시예 62Example 62 A-2A-2 4.24.2 6.16.1 451451 3737 실시예 63Example 63 A-3A-3 4.44.4 6.16.1 460460 3232 실시예 64Example 64 A-4A-4 4.34.3 6.06.0 461461 3939 실시예 65Example 65 A-5A-5 4.34.3 6.16.1 461461 4444 실시예 66Example 66 A-6A-6 4.24.2 6.36.3 462462 4545 실시예 67Example 67 A-7A-7 4.74.7 6.16.1 463463 3232 실시예 68Example 68 A-8A-8 4.34.3 6.16.1 457457 3939 실시예 69Example 69 B-1B-1 4.64.6 6.26.2 459459 3838 실시예 70Example 70 B-2B-2 4.54.5 6.06.0 459459 3737 실시예 71Example 71 B-3B-3 4.84.8 6.16.1 459459 3232 실시예 72Example 72 B-4B-4 4.34.3 6.16.1 451451 3939 실시예 73Example 73 B-5B-5 4.44.4 6.36.3 459459 4444 실시예 74Example 74 B-6B-6 4.34.3 6.06.0 459459 4545 실시예 75Example 75 B-7B-7 4.24.2 6.26.2 459459 4545 실시예 76Example 76 B-8B-8 4.24.2 6.16.1 451451 3232 실시예 77Example 77 C-1C-1 4.34.3 6.16.1 460460 3939 실시예 78Example 78 C-2C-2 4.74.7 6.06.0 460460 3838 실시예 79Example 79 C-3C-3 4.24.2 6.16.1 459459 3737 실시예 80Example 80 C-4C-4 4.84.8 6.26.2 459459 3232 실시예 81Example 81 C-5C-5 4.94.9 6.16.1 451451 3939 실시예 82Example 82 C-6C-6 4.54.5 6.16.1 460460 4444 실시예 83Example 83 C-7C-7 4.34.3 6.06.0 461461 4242 실시예 84Example 84 C-8C-8 4.24.2 6.06.0 461461 4444 실시예 85Example 85 D-1D-1 4.24.2 6.06.0 462462 4343 실시예 86Example 86 D-2D-2 4.94.9 6.26.2 463463 4848 실시예 87Example 87 D-3D-3 4.64.6 6.46.4 460460 4949 실시예 88Example 88 D-4D-4 4.34.3 6.06.0 459459 4141 실시예 89Example 89 D-5D-5 4.64.6 6.06.0 459459 4848 실시예 90Example 90 D-6D-6 4.34.3 6.06.0 451451 4949 실시예 91Example 91 D-7D-7 4.14.1 6.26.2 460460 4141 실시예 92Example 92 D-8D-8 4.34.3 6.46.4 461461 4242

샘플Sample 수명 개선층life improvement layer 구동전압 (V)Driving voltage (V) 전류효율 (cd/A)Current efficiency (cd/A) 발광 피크 (nm)Emission peak (nm) 수명 (hr, T97)Life (hr, T 97 ) 실시예 93Example 93 E-1E-1 4.24.2 6.36.3 461461 4747 실시예 94Example 94 E-2E-2 4.44.4 6.46.4 462462 4343 실시예 95Example 95 E-3E-3 4.84.8 6.26.2 463463 4848 실시예 96Example 96 E-4E-4 4.44.4 6.16.1 469469 4949 실시예 97Example 97 E-5E-5 4.74.7 6.06.0 461461 4141 실시예 98Example 98 E-6E-6 4.54.5 6.06.0 462462 4848 실시예 99Example 99 E-7E-7 4.94.9 6.06.0 463463 4949 실시예 100Example 100 E-8E-8 4.64.6 6.06.0 469469 4141 비교예 4Comparative Example 4 -- 4.74.7 5.65.6 458458 3232 비교예 5Comparative Example 5 BCPBCP 5.35.3 5.95.9 458458 2828

상기 표 5 및 6에 나타낸 바와 같이, 본 발명에 따른 화합물을 수명 개선층에 사용한 청색 유기 전계 발광 소자(실시예 61 내지 100)는 수명 개선층을 사용하지 않는 청색 유기 전계 발광 소자(비교예 4)에 비해 전류 효율 및 수명이 우수한 것을 확인할 수 있었고, 종래 BCP를 수명 개선층에 사용한 청색 유기 전계 발광 소자(비교예 5)에 비해 구동전압 전류 효율이 우수할 뿐만 아니라, 수명이 현저하게 향상된 것을 확인할 수 있었다.As shown in Tables 5 and 6, the blue organic electroluminescent device (Examples 61 to 100) using the compound according to the present invention in the lifetime improvement layer is a blue organic EL device without using the lifetime improvement layer (Comparative Example 4 ), it was confirmed that the current efficiency and lifespan were excellent, and the driving voltage current efficiency was excellent compared to the blue organic electroluminescent device (Comparative Example 5) using the conventional BCP for the lifespan improvement layer, and the lifespan was significantly improved. I was able to confirm.

[[ 실시예Example 101 내지 110] 청색 유기 101 to 110] blue organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

합성예에서 합성된 화합물 A-1, A-6, B-1, B-6, C-1, C-6, D-1, D-6, E-1, E-6을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 청색 유기 전계 발광 소자를 제조하였다.Compounds A-1, A-6, B-1, B-6, C-1, C-6, D-1, D-6, E-1, E-6 synthesized in Synthesis Example were prepared by commonly known methods. After sublimation purification with high purity, a blue organic electroluminescent device was prepared as follows.

먼저, ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고, 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water and ultrasonic waves. After the distilled water cleaning is finished, ultrasonic cleaning is performed with solvents such as isopropyl alcohol, acetone, and methanol, and after drying, the substrate is transferred to a UV OZONE cleaner (Power Sonic 405, Hwashin Tech), and then the substrate is cleaned using UV for 5 minutes. After cleaning, the substrate was transferred to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (㈜두산전자, 80 nm)/NPB (15 nm)/AND + 5%의 DS-405(㈜두산전자) (30 nm)/각각의 화합물 A-1, A-6, B-1, B-6, C-1, C-6, D-1, D-6, E-1, E-6 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.On the ITO transparent electrode prepared as above, DS-205 (Doosan Electronics, 80 nm)/NPB (15 nm)/AND + 5% DS-405 (Doosan Electronics) (30 nm)/each compound A- 1, A-6, B-1, B-6, C-1, C-6, D-1, D-6, E-1, E-6 (30 nm) / LiF (1 nm) / Al ( 200 nm) to prepare an organic electroluminescent device.

[[ 비교예comparative example 6] 청색 유기 6] Blue organic 전계electric field 발광 소자의 제조 Manufacture of Light-Emitting Devices

전자 수송층 형성시 전자 수송층 물질로서 화합물 A-1 대신 Alq3을 사용하는 것을 제외하고는, 상기 실시예 101과 동일한 과정으로 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 101, except that Alq 3 was used instead of Compound A-1 as the electron transport layer material when forming the electron transport layer.

[[ 평가예evaluation example 5] 5]

실시예 101 내지 110 및 비교예 6에서 각각 제조된 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율, 발광피크를 측정하였고, 그 결과를 하기 표 7에 나타내었다.Driving voltage, current efficiency, and emission peak at a current density of 10 mA/cm 2 were measured for the organic electroluminescent devices prepared in Examples 101 to 110 and Comparative Example 6, respectively, and the results are shown in Table 7 below.

샘플Sample 전자 수송층electron transport layer 구동전압 (V)Driving voltage (V) 전류효율 (V)Current efficiency (V) 발광피크 (nm)Emission peak (nm) 실시예 101Example 101 A-1A-1 4.24.2 6.36.3 462462 실시예 102Example 102 A-6A-6 4.04.0 6.16.1 460460 실시예 103Example 103 B-1B-1 4.14.1 5.85.8 457457 실시예 104Example 104 B-6B-6 4.64.6 5.85.8 463463 실시예 105Example 105 C-1C-1 4.54.5 6.16.1 460460 실시예 106Example 106 C-6C-6 4.64.6 5.85.8 457457 실시예 107Example 107 D-1D-1 4.54.5 5.85.8 463463 실시예 108Example 108 D-6D-6 4.24.2 5.85.8 462462 실시예 109Example 109 E-1E-1 4.04.0 6.06.0 460460 실시예 110Example 110 E-6E-6 4.14.1 6.16.1 463463 비교예 6Comparative Example 6 -- 4.74.7 5.65.6 458458

상기 표 7에 나타낸 바와 같이, 본 발명에 따른 화합물을 전자 수송층에 사용한 청색 유기 전계 발광 소자(실시예 101 내지 110)는 전자 수송층을 사용하지 않는 청색 유기 전계 발광 소자(비교예 4)에 비해 구동전압 및 전류 효율이 우수한 것을 확인할 수 있었다.As shown in Table 7, the blue organic electroluminescent device (Examples 101 to 110) using the compound according to the present invention in the electron transport layer is driven compared to the blue organic electroluminescent device (Comparative Example 4) without using the electron transport layer. It was confirmed that the voltage and current efficiency were excellent.

이와 같이, 본 발명에 따른 화학식 1로 표시되는 화합물을 수명 개선층이나 전자 수송층에 사용한 유기 전계 발괄 소자는 구동전압 및 전류 효율이 향상되고, 나아가 수명 특성이 크게 향상될 수 있다는 것을 확인할 수 있었다.As such, it was confirmed that the driving voltage and current efficiency of the organic field generating device using the compound represented by Formula 1 according to the present invention in the lifespan improvement layer or the electron transport layer can be improved, and furthermore, the lifespan characteristics can be greatly improved.

Claims (9)

삭제delete 삭제delete 삭제delete 삭제delete 하기 화학식 8로 표시되는 것이 특징인 화합물:
[화학식 8]
Figure 112023022993082-pat00112

상기 화학식 8에서,
Ar1은 C6~C60의 아릴기, 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택되고;
Y1 내지 Y12는 서로 동일하거나 상이하며, 각각 독립적으로 N 또는 C이고;
a 내지 c는 각각 독립적으로 0 내지 4의 정수로서, a 내지 c가 각각 독립적으로 1 내지 3의 정수인 경우, R1 내지 R3은 서로 동일하거나 상이하며, 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있고, 이때 R1 내지 R3이 각각 복수인 경우, 이들은 동일하거나 상이하며;
상기 Ar1, R1 내지 R3의 알킬기, 아릴기, 헤테로아릴기, 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하며,
다만 상기 Ar1, R1 내지 R3 중 적어도 하나는 하기 화학식 12로 표시되는 치환체이며,
[화학식 12]
Figure 112023022993082-pat00118

상기 화학식 12에서,
*는 상기 화학식 8에 결합되는 부분을 의미하고;
L1은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택되고;
Z1 내지 Z5는 서로 동일하거나 상이하며, 각각 독립적으로 N 또는 C(R7)이며, 다만 Z1 내지 Z5 중 적어도 하나는 N이고, 이때 상기 R7이 복수인 경우, 이들은 서로 동일하거나 상이하고;
R7은 수소, 중수소, C1~C40의 알킬기, 및 C6~C60의 아릴기로 이루어진 군에서 선택되거나, 또는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며;
상기 L1의 아릴렌기 및 헤테로아릴렌기와, R7의 알킬기, 아릴기는 각각 독립적으로 중수소, 할로겐, 시아노, C6~C60의 아릴기, 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있으며, 이때 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다.
A compound characterized by being represented by Formula 8:
[Formula 8]
Figure 112023022993082-pat00112

In Formula 8,
Ar 1 is selected from the group consisting of a C 6 ~ C 60 aryl group and a heteroaryl group having 5 to 60 nuclear atoms;
Y 1 to Y 12 are the same as or different from each other, and are each independently N or C;
a to c are each independently an integer of 0 to 4, and when a to c are each independently an integer of 1 to 3, R 1 to R 3 are the same as or different from each other, and each independently deuterium, a halogen, a cyano group, It is selected from the group consisting of a nitro group, a C 1 ~ C 40 alkyl group, a C 6 ~ C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, and a C 6 ~ C 60 arylamine group, or an adjacent group may combine to form a condensed ring, wherein, when R 1 to R 3 are each plural, they are the same or different;
The Ar 1 , R 1 to R 3 alkyl group, aryl group, heteroaryl group, and arylamine group are each independently deuterium, halogen, cyano, C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, It may be substituted with one or more substituents selected from the group consisting of a heteroaryl group having 5 to 60 nuclear atoms, and an arylamine group having C 6 ~ C 60 , wherein when the substituents are plural, they are the same as or different from each other,
However, at least one of Ar 1 , R 1 to R 3 is a substituent represented by Formula 12 below,
[Formula 12]
Figure 112023022993082-pat00118

In Formula 12,
* means a moiety bonded to Formula 8;
L 1 is a single bond, or is selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms;
Z 1 to Z 5 are the same as or different from each other, and are each independently N or C(R 7 ), provided that at least one of Z 1 to Z 5 is N, wherein, when the R 7 is plural, they are the same as or different;
R 7 is selected from the group consisting of hydrogen, heavy hydrogen, a C 1 ~ C 40 alkyl group, and a C 6 ~ C 60 aryl group, or may combine with an adjacent group to form a condensed ring;
The arylene group and heteroarylene group of L 1 , the alkyl group and aryl group of R 7 are each independently composed of deuterium, halogen, cyano, C 6 ~ C 60 aryl group, and a heteroaryl group having 5 to 60 nuclear atoms. It may be substituted with one or more substituents selected from the group, and in this case, when the substituents are plural, they may be the same as or different from each other.
삭제delete 제5항에 있어서,
상기 화학식 12의 치환체는 하기 화학식 A1 내지 A15로 표시되는 치환체 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
Figure 112023022993082-pat00117

상기 화학식 A1 내지 A15에서,
L1 및 R7은 각각 제5항에서 정의한 바와 같고;
n은 0 내지 4의 정수로서, n이 1 내지 4의 정수일 경우, R8는 각각 독립적으로 중수소, C1~C40의 알킬기, 및 C6~C60의 아릴기로 이루어진 군에서 선택되며, 이때 상기 R8가 복수인 경우, 이들은 서로 동일하거나 상이할 수 있다.
According to claim 5,
A compound characterized in that the substituent of Formula 12 is represented by any one of the substituents represented by the following Formulas A1 to A15:
Figure 112023022993082-pat00117

In the above formulas A1 to A15,
L 1 and R 7 are each as defined in claim 5;
n is an integer of 0 to 4, and when n is an integer of 1 to 4, each R 8 is independently selected from the group consisting of deuterium, a C 1 to C 40 alkyl group, and a C 6 to C 60 aryl group, wherein When the R 8 is plural, they may be the same as or different from each other.
양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하고,
상기 1층 이상의 유기물층 중에서 적어도 하나는 제5항 또는 제7항 중 어느 한 항에 기재된 화합물을 포함하는 유기 전계 발광 소자.
Including an anode, a cathode and one or more organic material layers interposed between the anode and the cathode,
An organic electroluminescent device wherein at least one of the one or more organic material layers contains the compound according to any one of claims 5 or 7.
제8항에 있어서,
상기 화합물을 포함하는 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광층, 수명 개선층, 전자 수송층 및 전자 주입층으로 이루어진 군에서 선택되는 것이 특징인 유기 전계 발광 소자.


According to claim 8,
An organic electroluminescent device, wherein the one or more organic material layers containing the compound are selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, a lifespan improvement layer, an electron transport layer, and an electron injection layer.


KR1020150171546A 2015-12-03 2015-12-03 Organic light-emitting compound and organic electroluminescent device using the same KR102530095B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020150171546A KR102530095B1 (en) 2015-12-03 2015-12-03 Organic light-emitting compound and organic electroluminescent device using the same
PCT/KR2016/013721 WO2017095086A1 (en) 2015-12-03 2016-11-25 Organic light-emitting compound and organic electroluminescent device using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150171546A KR102530095B1 (en) 2015-12-03 2015-12-03 Organic light-emitting compound and organic electroluminescent device using the same

Publications (2)

Publication Number Publication Date
KR20170065291A KR20170065291A (en) 2017-06-13
KR102530095B1 true KR102530095B1 (en) 2023-05-09

Family

ID=58797051

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150171546A KR102530095B1 (en) 2015-12-03 2015-12-03 Organic light-emitting compound and organic electroluminescent device using the same

Country Status (2)

Country Link
KR (1) KR102530095B1 (en)
WO (1) WO2017095086A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105845831B (en) * 2015-01-30 2019-07-05 三星显示有限公司 Organic light emitting apparatus
KR20180138267A (en) * 2017-06-20 2018-12-31 삼성디스플레이 주식회사 Condensed cyclic compound and organic light emitting device comprising the same
KR102207894B1 (en) * 2018-03-30 2021-01-26 삼성에스디아이 주식회사 Organic compound and organic optoelectronic device and display device
KR102663763B1 (en) * 2019-07-22 2024-05-07 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
CN110903280B (en) * 2019-12-06 2021-08-03 宁波卢米蓝新材料有限公司 Organic compound and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015099481A1 (en) 2013-12-27 2015-07-02 주식회사 두산 Organic electroluminescent device
WO2016013894A2 (en) 2014-07-24 2016-01-28 주식회사 두산 Organic compound and organic electroluminescent device comprising same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001160489A (en) 1999-12-01 2001-06-12 Toyota Central Res & Dev Lab Inc Organic electroluminescent element
KR101667099B1 (en) * 2013-03-29 2016-10-17 주식회사 엘지화학 Heterocyclic compound and organic light emitting device comprising the same
KR101641404B1 (en) * 2013-12-17 2016-07-20 주식회사 두산 Organic compound and organic electroluminescent device comprising the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015099481A1 (en) 2013-12-27 2015-07-02 주식회사 두산 Organic electroluminescent device
WO2016013894A2 (en) 2014-07-24 2016-01-28 주식회사 두산 Organic compound and organic electroluminescent device comprising same

Also Published As

Publication number Publication date
WO2017095086A1 (en) 2017-06-08
KR20170065291A (en) 2017-06-13

Similar Documents

Publication Publication Date Title
KR102487503B1 (en) Organic compound and organic electroluminescent device using the same
KR102283293B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102499850B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102508486B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101729372B1 (en) Organic compound and organic electroluminescent device comprising the same
KR102248650B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101776193B1 (en) Organic compound and organic electroluminescent device comprising the same
KR102530095B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101561338B1 (en) Organic compounds and organic electro luminescence device comprising the same
JP2019503364A (en) Organic compound and organic electroluminescent device containing the same
KR101506793B1 (en) Organic electro luminescence device
KR102307239B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20190087280A (en) Organic compound and organic electroluminescent device using the same
KR101827067B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102617611B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102552358B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150008678A (en) Organic compounds and organic electro luminescence device comprising the same
KR20230040969A (en) Organic compound and organic electroluminescent device using the same
KR20150103968A (en) Organic compounds and organic electro luminescence device comprising the same
KR101641411B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102307237B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101577099B1 (en) Organic compound and organic electroluminescent device comprising the same
KR102673121B1 (en) Organic compound and organic electroluminescent device using the same
KR102599413B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102507371B1 (en) Organic light-emitting compound and organic electroluminescent device using the same

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant